Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products

Michael John PeckMichael Peck Consulting Services, Thielle, Switzerland; Correspondence[email protected]

Edward B. SandersSanders Consulting Services, Peseux, Switzerland;

Gerhard SchererABF Laboratories, GmbH, Munich, Germany;

Frank LüdickeResearch & Development, Philip Morris International, Neuchâtel, Switzerland

Rolf WeitkunatResearch & Development, Philip Morris International, Neuchâtel, Switzerland

References

Aaron, C.P., et al., 2015. Intercellular adhesion molecule 1 and progression of percent emphysema: the MESA lung study. Respiratory medicine, 109, 255–264.
PubMed Web of Science ®Google Scholar
Abdi, A.I., et al., 2014. Measuring soluble ICAM-1 in African populations. PLoS one, 9, e108956.
PubMed Web of Science ®Google Scholar
Adukauskiene, D., et al., 2016. Clinical relevance of high sensitivity C-reactive protein in cardiology. Medicina (Kaunas), 52, 1–10.
PubMed Web of Science ®Google Scholar
Agaku, I.T., Vardavas, C.I., and Connolly, G.N., 2014. Cigarette rod length and its impact on serum cotinine and urinary total NNAL levels, NHANES 2007-2010. Nicotine &Amp; tobacco research, 16, 100–107.
PubMed Web of Science ®Google Scholar
Agarwal, R., et al., 2013. The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease. Multidisciplinary respiratory medicine, 8, 63.
PubMed Web of Science ®Google Scholar
Aggarwal, A.N., Gupta, D., and Jindal, S.K., 2006. The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor. Chest, 130, 1454–1461.
PubMed Web of Science ®Google Scholar
Ahn, J., et al., 2009. Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer epidemiology, biomarkers & prevention, 18, 2814–2821.
PubMed Web of Science ®Google Scholar
Al-Awadhi, A.M., et al., 2008. Effects of cigarette smoking on hematological parameters and von Willebrand factor functional activity levels in asymptomatic male and female Arab smokers. Medical principles and practice, 17, 149–153.
PubMed Web of Science ®Google Scholar
Al Ghobain, M.O., et al., 2014. Spirometric reference values for healthy nonsmoking Saudi adults. The clinical respiratory journal, 8, 72–78.
PubMed Web of Science ®Google Scholar
Al Rifai, M., et al., 2017. The relationship between smoking intensity and subclinical cardiovascular injury: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis, 258, 119–130.
PubMed Web of Science ®Google Scholar
Allen, S.S., Hatsukami, D., and Gorsline, J., 1994. Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group. Preventive medicine, 23, 190–196.
PubMed Web of Science ®Google Scholar
Allin, K.H., Bojesen, S.E., and Nordestgaard, B.G., 2016. Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population. International journal of cancer, 139, 1493–1500.
PubMed Web of Science ®Google Scholar
An, G., et al., 2016. A novel physiology-based mathematical model to estimate red blood cell lifespan in different human age groups. The AAPS journal, 18, 1182–1191.
PubMed Web of Science ®Google Scholar
Anan, F., et al., 2006. Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. European journal of clinical investigation, 36, 459–465.
PubMed Web of Science ®Google Scholar
Anatoliotakis, N., et al., 2013. Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease. Current topics in medicinal chemistry, 13, 115–138.
PubMed Web of Science ®Google Scholar
Andelid, K., et al., 2007. Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms. Respiratory medicine, 101, 888–895.
PubMed Web of Science ®Google Scholar
Andersson, A., et al., 2001. Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease. Clinical chemistry and laboratory medicine, 39, 229–233.
PubMed Web of Science ®Google Scholar
Annor, F., et al., 2017. African ancestry gradient is associated with lower systemic F2-isoprostane levels. Oxidative medicine and cellular longevity, 2017, 8319176.
PubMedGoogle Scholar
Anthonisen, N.R., et al., 1994. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA, 272, 1497–1505.
PubMed Web of Science ®Google Scholar
Antonopoulos, C.N., et al., 2014. The role of soluble P selectin in the diagnosis of venous thromboembolism. Thrombosis research, 133, 17–24.
PubMed Web of Science ®Google Scholar
Arican, O., et al., 2005. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators of inflammation, 2005, 273–279.
PubMed Web of Science ®Google Scholar
Ashley, D.L., et al., 2003. Tobacco-specific nitrosamines in tobacco from U.S. brand and non-U.S. brand cigarettes. Nicotine & tobacco research, 5, 323–331.
PubMed Web of Science ®Google Scholar
Asthana, A., et al., 2010. Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. American heart journal, 160, 458–463.
PubMed Web of Science ®Google Scholar
Baccarelli, A., et al., 2007. Air pollution, smoking, and plasma homocysteine. Journal of thrombosis and haemostasis, 115, 176–181.
Google Scholar
Baggio, B., et al., 2002. Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. Journal of the American society of nephrology, 13, 2730–2736.
PubMed Web of Science ®Google Scholar
Balasubramaniam, M., Sivapalan, K., and Thuvarathipan, R., 2014. Lung function parameters of healthy Sri Lankan Tamil young adults. Ceylon medical journal, 59, 49–53.
PubMedGoogle Scholar
Baldawa, P.S., et al., 2016. Levels of salivary thiocyanate and its relation with occurrence of micronuclei using exfoliative cytology in smokers and nonsmokers. Indian journal of dental research, 27, 568–573.
PubMedGoogle Scholar
Baldus, S., et al., 2003. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation, 108, 1440–1445.
PubMed Web of Science ®Google Scholar
Ballman, K.V., 2015. Biomarker: predictive or prognostic?. Journal of clinical oncology, 33, 3968–3971.
PubMed Web of Science ®Google Scholar
Barnes, P.J., 2009. The cytokine network in chronic obstructive pulmonary disease. American journal of respiratory cell and molecular biology, 41, 631–638.
PubMed Web of Science ®Google Scholar
Barrera, G., 2012. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN oncology, 2012, 137289.
PubMedGoogle Scholar
Barrow, S.E., et al., 1989. Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. Biochimica et biophysica acta, 993 (1), 121–127.
PubMedGoogle Scholar
Bartholo, T.P., Costa, C.H., and Rufino, R., 2014. Evaluation of von Willebrand factor in COPD patients. Jornal brasileiro de pneumologia, 40, 373–379.
PubMed Web of Science ®Google Scholar
Bartsch, H., et al., 1989. Human exposure to endogenous N-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. Cancer surveys, 8, 335–362.
PubMedGoogle Scholar
Barua, R.S., et al., 2001. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation, 104, 1905–1910.
PubMed Web of Science ®Google Scholar
Bauman, W.A., et al., 1998. Ethnicity effect on the serum lipid profile in persons with spinal cord injury. Archives of physical medicine and rehabilitation, 79, 176–180.
PubMed Web of Science ®Google Scholar
Bazzano, L.A., et al., 2003. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Annals of internal medicine, 138, 891–897.
PubMed Web of Science ®Google Scholar
Becklake, M.R., 1986. Concepts of normality applied to the measurement of lung function. The American journal of medicine, 80, 1158–1164.
PubMed Web of Science ®Google Scholar
Belda, J., et al., 2000. Induced sputum cell counts in healthy adults. American journal of respiratory and critical care medicine, 161, 475–478.
PubMed Web of Science ®Google Scholar
Bellisarii, F.L., Gallina, S., and De Caterina, R., 2001. Tumor necrosis factor-alpha and cardiovascular diseases. Italian heart journal, 2, 408–417.
PubMedGoogle Scholar
Benowitz, N.L., et al., 2012. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer epidemiology, biomarkers & prevention, 21, 761–769.
PubMed Web of Science ®Google Scholar
Bermudez, E.A., et al., 2002. Relation between markers of systemic vascular inflammation and smoking in women. American journal of cardiology, 89, 1117–1119.
PubMed Web of Science ®Google Scholar
Bhatt, S.P., et al., 2016. Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 194, 178–184.
PubMed Web of Science ®Google Scholar
Bialas, A.J., et al., 2016. The role of mitochondria and oxidative/antioxidative imbalance in pathobiology of chronic obstructive pulmonary disease. Oxidative medicine and cellular longevity, 2016, 7808576.
PubMedGoogle Scholar
Bielinski, S.J., et al., 2015. P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis, 240, 3–9.
PubMed Web of Science ®Google Scholar
Biomarkers Definitions Working Group, 2001. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical pharmacology & therapeutics, 69, 89–95.
PubMed Web of Science ®Google Scholar
Bird, Y. and Staines-Orozco, H., 2016. Pulmonary effects of active smoking and secondhand smoke exposure among adolescent students in Juarez, Mexico. International journal of chronic obstructive pulmonary disease, 11, 1459–1467.
PubMed Web of Science ®Google Scholar
Bjerg, A., et al., 2013. Higher risk of wheeze in female than male smokers. Results from the Swedish GA 2 LEN study. PLoS one, 8, e54137.
PubMed Web of Science ®Google Scholar
Bjorkhem, I., 2002. Do oxysterols control cholesterol homeostasis? The journal of clinical investigation, 110, 725–730.
PubMed Web of Science ®Google Scholar
Bjorkhem, I., Meaney, S., and Diczfalusy, U., 2002. Oxysterols in human circulation: which role do they have?. Current opinion in lipidology, 13, 247–253.
PubMed Web of Science ®Google Scholar
Blann, A.D., 2006. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thrombosis and haemostasis, 95, 49–55.
PubMed Web of Science ®Google Scholar
Blann, A.D., et al., 1997a. Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: relationship with von Willebrand factor. Blood Coagulation & Fibrinolysis, 8, 200–204.
PubMed Web of Science ®Google Scholar
Blann, A.D., et al., 1998. The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis, 141, 133–139.
PubMed Web of Science ®Google Scholar
Blann, A.D. and Mccollum, C.N., 1993. Adverse influence of cigarette smoking on the endothelium. Thrombosis and haemostasis, 70, 707–711.
PubMed Web of Science ®Google Scholar
Blann, A.D., Nadar, S.K., and Lip, G.Y., 2003. The adhesion molecule P-selectin and cardiovascular disease. European heart journal, 24, 2166–2179.
PubMed Web of Science ®Google Scholar
Blann, A.D., Steele, C., and Mccollum, C.N., 1997b. The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Thrombosis and haemostasis, 78, 1093–1096.
PubMed Web of Science ®Google Scholar
Blann, A.D., Steele, C., and Mccollum, C.N., 1997c. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thrombosis research, 85, 433–438.
PubMed Web of Science ®Google Scholar
Blidberg, K., et al., 2013. Adhesion molecules in subjects with COPD and healthy non-smokers: a cross sectional parallel group study. Respiratory research, 14, 47.
PubMed Web of Science ®Google Scholar
Boeing, H., et al., 2000. Association between glycated hemoglobin and diet and other lifestyle factors in a nondiabetic population: cross-sectional evaluation of data from the Potsdam cohort of the European Prospective Investigation into Cancer and Nutrition Study. The American journal of clinical nutrition, 71, 1115–1122.
PubMed Web of Science ®Google Scholar
Boltri, J.M., et al., 2005. Hemoglobin A1c levels in diagnosed and undiagnosed black, Hispanic, and white persons with diabetes: results from NHANES 1999-2000. Ethnicity & disease, 15, 562–567.
PubMed Web of Science ®Google Scholar
Borrill, Z.L., et al., 2008. Non-invasive biomarkers and pulmonary function in smokers. International journal of chronic obstructive pulmonary disease, 3, 171–183.
PubMedGoogle Scholar
Bostrom, L., Linder, L.E., and Bergstrom, J., 1999. Smoking and crevicular fluid levels of IL-6 and TNF-alpha in periodontal disease. Journal of clinical periodontology, 26, 352–357.
PubMed Web of Science ®Google Scholar
Bottino, D.A., et al., 2015. Relationship between biomarkers of inflammation, oxidative stress and endothelial/microcirculatory function in successful aging versus healthy youth: a transversal study. BMC Geriatrics, 15, 41.
PubMed Web of Science ®Google Scholar
Bouloukaki, I., et al., 2009. Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers. Mediators of inflammation, 2009, 812102.
PubMedGoogle Scholar
Bozinovski, S., et al., 2016. COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link. British journal of pharmacology, 173, 635–648.
PubMed Web of Science ®Google Scholar
Brennan, M.L., et al., 2003. Prognostic value of myeloperoxidase in patients with chest pain. The new England journal of medicine, 349, 1595–1604.
PubMed Web of Science ®Google Scholar
Brignac-Huber, L., Reed, J.R., and Backes, W.L., 2011. Organization of NADPH-cytochrome P450 reductase and CYP1A2 in the endoplasmic reticulum–microdomain localization affects monooxygenase function. Molecular pharmacology, 79, 549–557.
PubMed Web of Science ®Google Scholar
Brilakis, E.S., et al., 2008. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study. Atherosclerosis, 199, 110–115.
PubMed Web of Science ®Google Scholar
Brindicci, C., et al., 2005. Exhaled nitric oxide from lung periphery is increased in COPD. The European respiratory journal, 26, 52–59.
PubMed Web of Science ®Google Scholar
Burgel, P.R., 2011. The role of small airways in obstructive airway diseases. European respiratory review, 20, 23–33.
PubMedGoogle Scholar
Busse, P.J., et al., 2017. Effect of aging on sputum inflammation and asthma control. The journal of allergy and clinical immunology, 139, 1808–1818.e6.
PubMed Web of Science ®Google Scholar
Butkiewicz, A.M., et al., 2006. Does smoking affect thrombocytopoiesis and platelet activation in women and men? Advances in medical science, 51, 123–126.
PubMedGoogle Scholar
Cahill, K., et al., 2013. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. The Cochrane database of systematic review, 5, CD009329.
PubMedGoogle Scholar
Calapai, G., et al., 2009. A cross-sectional investigation of biomarkers of risk after a decade of smoking. Inhalation toxicology, 21, 1138–1143.
PubMed Web of Science ®Google Scholar
Campagna, D., et al., 2016. Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. European journal of clinical investigation, 46, 698–706.
PubMed Web of Science ®Google Scholar
Campion, E.W., Delabry, L.O., and Glynn, R.J., 1988. The effect of age on serum albumin in healthy males: report from the Normative Aging Study. Journal of gerontology, 43, M18–M20.
PubMedGoogle Scholar
Carmella, S.G., et al., 2009. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chemical research in toxicology, 22, 734–741.
PubMed Web of Science ®Google Scholar
Carpagnano, G.E., et al., 2007. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients. Oncological research, 16, 375–381.
PubMed Web of Science ®Google Scholar
Carpagnano, G.E., et al., 2013. Aging and airway inflammation. Aging clinical and experimental research, 25, 239–245.
PubMed Web of Science ®Google Scholar
Carroll, A., 2016. Utilizing selection biomarkers in clinical trials: is this the future of drug development? Biomarkers in medicine, 10, 939–941.
PubMed Web of Science ®Google Scholar
Casale, R., et al., 1991. Impaired pulmonary function in schoolchildren exposed to passive smoking. Detection by questionnaire and urinary cotinine levels. Respiration, 58, 198–203.
PubMed Web of Science ®Google Scholar
Caslake, M.J. and Packard, C.J., 2003. Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease. Current opinion in lipidology, 14, 347–352.
PubMed Web of Science ®Google Scholar
Catella, F., et al., 1986. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proceedings of the national academy of sciences of the United States of America, 83, 5861–5865.
PubMed Web of Science ®Google Scholar
Cellai, A.P., et al., 2014. Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity. Journal of thrombosis and thrombolysis, 38, 45–49.
PubMed Web of Science ®Google Scholar
Celli, B.R., et al., 2012. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 185, 1065–1072.
PubMed Web of Science ®Google Scholar
Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US), 2010. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention.
Google Scholar
Cerveri, I., et al., 2008. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax, 63, 1040–1045.
PubMed Web of Science ®Google Scholar
Chalmers, G.W., et al., 2001. Smoking and airway inflammation in patients with mild asthma. Chest, 120, 1917–1922.
PubMed Web of Science ®Google Scholar
Chambers, D.C., Boldy, D.A., and Ayres, J.G., 1999. Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1. Respiratory medicine, 93, 726–733.
PubMed Web of Science ®Google Scholar
Chamnan, P., et al., 2013. Change in HbA1c over 3 years does not improve the prediction of cardiovascular disease over and above HbA1c measured at a single time point. Diabetologia, 56, 1004–1011.
PubMed Web of Science ®Google Scholar
Chan, S.C., et al., 2008. Upregulation of ICAM-1 expression in bronchial epithelial cells by airway secretions in bronchiectasis. Respiratory medicine, 102, 287–298.
PubMed Web of Science ®Google Scholar
Chang, M.H., et al., 2011. Racial/ethnic variation in the association of lipid-related genetic variants with blood lipids in the US adult population. Circulation: cardiovascular genetics, 4, 523–533.
PubMed Web of Science ®Google Scholar
Chase, H.P., et al., 1991. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA, 265, 614–617.
PubMed Web of Science ®Google Scholar
Chaudhuri, R., et al., 2014. Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils. Pulmonary pharmacology & therapeutics, 27, 62–69.
PubMed Web of Science ®Google Scholar
Chen, M. and Geng, J.G., 2006. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Archivum immunologiae et therapiae experimentalis, 54, 75–84.
PubMed Web of Science ®Google Scholar
Chen, S., et al., 2015. Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease. International journal of clinical and experimental medicine, 8, 4446–4454.
PubMed Web of Science ®Google Scholar
Chevrier, I., et al., 2003. Myeloperoxidase: new polymorphisms and relation with lung cancer risk. Pharmacogenetics, 13, 729–739.
PubMedGoogle Scholar
Choi, Y.J., et al., 2013. Changes in smoking behavior and adherence to preventive guidelines among smokers after a heart attack. Journal of geriatric cardiology, 10, 146–150.
Web of Science ®Google Scholar
Church, T.R., et al., 2009. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer epidemiology, biomarkers & prevention, 18, 260–266.
PubMed Web of Science ®Google Scholar
Cibella, F., et al., 2016. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes. Clinical science (London), 130, 1929–1937.
PubMed Web of Science ®Google Scholar
Cirillo, D.J., Agrawal, Y., and Cassano, P.A., 2002. Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey. American journal of epidemiology, 155, 842–848.
PubMed Web of Science ®Google Scholar
Clair, C., et al., 2011. Relationships of cotinine and self-reported cigarette smoking with hemoglobin A1c in the U.S.: results from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes care, 34, 2250–2255.
PubMed Web of Science ®Google Scholar
Coates, A.L., et al., 2016. Reference Equations for Spirometry in the Canadian Population. Annals of the American thoracic society, 13, 833–841.
PubMed Web of Science ®Google Scholar
Cohen, S.I., Deane, M., and Goldsmith, J.R., 1969. Carbon monoxide and survival from myocardial infarction. Archives of environmental health, 19, 510–517.
PubMed Web of Science ®Google Scholar
Cohen, W., et al., 2012. ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia. Arteriosclerosis, thrombosis, and vascular biology, 32, 2021–2028.
PubMed Web of Science ®Google Scholar
Committee on Human Biomonitoring for Environmental Toxicants. 2006. Human biomonitoring for environmental chemicals. Washington: National Academies Press.
Google Scholar
Committee on Scientific Standards for Studies on Modified Risk Tobacco Products. 2012. Scientific standards for studies on modified risk tobacco products (2012). Washington: The National Academies Press.
Google Scholar
Conese, M., et al., 2014. Evaluation of genome-wide expression profiles of blood and sputum neutrophils in cystic fibrosis patients before and after antibiotic therapy. PLoS one, 9, e104080.
PubMed Web of Science ®Google Scholar
Conlan, M.G., et al., 1993. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thrombosis and haemostasis, 70, 380–385.
PubMed Web of Science ®Google Scholar
Cooper, J.K. and Gardner, C., 1989. Effect of aging on serum albumin. Journal of the American geriatrics society, 37, 1039–1042.
PubMed Web of Science ®Google Scholar
Corradi, L., et al., 1993. Association between smoking and micro-albuminuria in hypertensive patients with type 2 diabetes mellitus. Journal of hypertension supplement, 11, S190–S191.
PubMedGoogle Scholar
Cosio, M., et al., 1978. The relations between structural changes in small airways and pulmonary-function tests. New England journal of medicine, 298, 1277–1281.
PubMed Web of Science ®Google Scholar
Cowman, J., et al., 2015. Age-related changes in platelet function are more profound in women than in men. Scientific reports, 5, 12235.
PubMed Web of Science ®Google Scholar
Craig, W.Y., Palomaki, G.E., and Haddow, J.E., 1989. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (clinical research ed.), 298, 784–788.
PubMed Web of Science ®Google Scholar
Crapo, R.O. and Jensen, R.L., 2003. Standards and interpretive issues in lung function testing. Respiratory care, 48, 764–772.
PubMedGoogle Scholar
Czoli, C.D. and Hammond, D., 2015. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users. Nicotine &Amp; tobacco research, 17, 825–830.
PubMed Web of Science ®Google Scholar
Dahl, M., et al., 2007. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 175, 250–255.
PubMed Web of Science ®Google Scholar
Dalaveris, E., et al., 2009. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung cancer, 64, 219–225.
PubMed Web of Science ®Google Scholar
Danesh, J., et al., 1998. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA, 279, 1477–1482.
PubMed Web of Science ®Google Scholar
Danesh, J., et al., 2004. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England journal of medicine, 350, 1387–1397.
PubMed Web of Science ®Google Scholar
Davidson, M.B. and Schriger, D.L., 2010. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes research and clinical practice, 87, 415–421.
PubMed Web of Science ®Google Scholar
De Bree, A., et al., 2002. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacological reviews, 54, 599–618.
PubMed Web of Science ®Google Scholar
Dedonder-Decoopman, E., et al., 1980. Plasma levels of VLDL- + LDL-cholesterol, HDL-cholesterol, triglycerides and apoproteins B and A-I in a healthy population–influence of several risk factors. Atherosclerosis, 37, 559–568.
PubMed Web of Science ®Google Scholar
Delporte, C., et al., 2013. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators of inflammation, 2013, 971579.
PubMed Web of Science ®Google Scholar
Deneva-Koycheva, T.I., et al., 2011. Serum levels of siCAM-1, sVCAM-1, sE-selectin, sP-selectin in healthy Bulgarian people. Folia medicine (Plovdiv), 53, 22–28.
PubMedGoogle Scholar
Deng, Z.C., et al., 2014. C-reactive protein as a prognostic marker in chronic obstructive pulmonary disease. Experimental and therapeutic medicine, 7, 443–446.
PubMed Web of Science ®Google Scholar
Derin, D., et al., 2008. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer. Lung cancer (Amsterdam, Netherlands), 59, 240–245.
PubMed Web of Science ®Google Scholar
Diaz-Guzman, E. and Mannino, D.M., 2014. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clinics in chest medicine, 35, 7–16.
PubMed Web of Science ®Google Scholar
Dicpinigaitis, P.V., et al., 2016. Effect of e-cigarette use on cough reflex sensitivity. Chest, 149, 161–165.
PubMed Web of Science ®Google Scholar
Diczfalusy, U., et al., 2008. 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians. Pharmacogenetics and genomics, 18, 201–208.
PubMed Web of Science ®Google Scholar
Dogne, J.M., Hanson, J., and Pratico, D., 2005. Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis. Trends in pharmacological science, 26, 639–644.
PubMed Web of Science ®Google Scholar
Dominguez-Rodriguez, A., and Abreu-Gonzalez, P., 2011. Current role of myeloperoxidase in routine clinical practice. Expert review of cardiovascular therapy, 9, 223–230.
PubMedGoogle Scholar
Dotevall, A., et al., 1992. Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females. Thrombosis and haemostasis, 68, 583–588.
PubMed Web of Science ®Google Scholar
Drenos, F., Miller, G.J., and Humphries, S.E., 2007. Increase of plasma fibrinogen levels and variability with age in a sample of middle aged healthy men. Annals of human genetics, 71, 43–53.
PubMed Web of Science ®Google Scholar
Drucker, E. and Krapfenbauer, K., 2013. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA journal, 4, 7.
PubMedGoogle Scholar
Eeg-Olofsson, K., et al., 2010. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Journal of internal medicine, 268, 471–482.
PubMed Web of Science ®Google Scholar
Eikelboom, J.W., et al., 2002. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation, 105, 1650–1655.
PubMed Web of Science ®Google Scholar
Ekim, M., et al., 2015. Study on relationships among deep vein thrombosis, homocysteine & related B group vitamins. Pakistan journal of medical sciences, 31, 398–402.
PubMed Web of Science ®Google Scholar
El-Sammak, M., et al., 2004. Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects. International journal of medical science, 1, 181–192.
PubMedGoogle Scholar
Ernst, E. and Resch, K.L., 1993. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Annals of internal medicine, 118, 956–963.
PubMed Web of Science ®Google Scholar
Everett, C.J., et al., 2007. Smoking, fibrinogen and cancer mortality. Journal of the national medical association, 99, 328–333.
PubMed Web of Science ®Google Scholar
Fatima, N., et al., 2017. Emerging role of Interleukins IL-23/IL-17 axis and biochemical markers in the pathogenesis of type 2 diabetes: association with age and gender in human subjects. International journal of biological macromolecules, 105, 1279–1288.
PubMed Web of Science ®Google Scholar
Faux, S.P., et al., 2009. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers, 14Suppl1, 90–96.
Google Scholar
Ference, B.A. and Mahajan, N., 2013. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. Journal of the American college of cardiology, 61, 1931–1932.
PubMedGoogle Scholar
Fernandez, J.A., et al., 2012. Systemic inflammation in 222.841 healthy employed smokers and nonsmokers: white blood cell count and relationship to spirometry. Tobacco induced diseases, 10, 7.
PubMed Web of Science ®Google Scholar
Fimognari, F.L., et al., 2009. Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease. Nutrition, metabolism and cardiovascular disease, 19, 654–659.
PubMed Web of Science ®Google Scholar
Firouzjahi, A., et al., 2013. Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from Iran. Inflammation, 36, 1122–1128.
PubMed Web of Science ®Google Scholar
Fleming, T.R. and Demets, D.L., 1996. Surrogate end points in clinical trials: are we being misled?. Annals of internal medicine, 125, 605–613.
PubMed Web of Science ®Google Scholar
Flenley, D.C., 1988. Chronic obstructive pulmonary disease. Disease-a-month, 34, 537–599.
PubMed Web of Science ®Google Scholar
Ford, E.S., et al., 2013. COPD surveillance-United States, 1999-2011. Chest, 144, 284–305.
PubMed Web of Science ®Google Scholar
Forey, B.A., et al., 2013. The effect of quitting smoking on HDL-cholesterol – a review based on within-subject changes. Biomarker research, 1, 26
PubMedGoogle Scholar
Foss, O.P. and Lund-Larsen, P.G., 1986. Serum thiocyanate and smoking: interpretation of serum thiocyanate levels observed in a large health study. Scandinavian journal of clinical and laboratory investigation, 46, 245–251.
PubMed Web of Science ®Google Scholar
Franchini, M. and Lippi, G., 2007. The role of von Willebrand factor in hemorrhagic and thrombotic disorders. Critical reviews in clinical laboratory sciences, 44, 115–149.
PubMed Web of Science ®Google Scholar
Franchini, M. and Mannucci, P.M., 2008. Von Willebrand factor: another janus-faced hemostasis protein. Seminars in thrombosis and hemostasis, 34, 663–669.
PubMed Web of Science ®Google Scholar
Frankel, D.S., et al., 2008. Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the Framingham offspring study. Circulation, 118, 2533–2539.
PubMed Web of Science ®Google Scholar
Fratta Pasini, A., et al., 2013. Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2? PLoS one, 8, e83092.
PubMed Web of Science ®Google Scholar
Freedman, B.I., et al., 2005. Relationship between albuminuria and cardiovascular disease in Type 2 diabetes. Journal of the American society of nephrology, 16, 2156–2161.
PubMed Web of Science ®Google Scholar
Freeman, D.J., et al., 1993. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. European journal of clinical investigation, 23, 630–640.
PubMed Web of Science ®Google Scholar
Friedman, G.D., et al., 1973. Smoking habits and the leukocyte count. Archives of environmental health, 26, 137–143.
PubMed Web of Science ®Google Scholar
Frondelius, K., et al., 2017. Lifestyle and dietary determinants of serum apolipoprotein A1 and apolipoprotein B concentrations: cross-sectional analyses within a Swedish cohort of 24,984 individuals. Nutrients, 9, 211.
PubMed Web of Science ®Google Scholar
Frost-Pineda, K., et al., 2011. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine & tobacco research, 13, 182–193.
PubMed Web of Science ®Google Scholar
Fu, A. and Nair, K.S., 1998. Age effect on fibrinogen and albumin synthesis in humans. The American journal of physiology, 275, E1023–E1030.
PubMed Web of Science ®Google Scholar
Garcia-Larsen, V., et al., 2014. Ventilatory function and cardiovascular disease risk factors: a cross-sectional study in young adults. BMC pulmonary medicine, 14, 206.
PubMed Web of Science ®Google Scholar
Garey, K.W., et al., 2004. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest, 125, 22–26.
PubMed Web of Science ®Google Scholar
Ge, P.C., et al., 2016. Synergistic Effect of Lipoprotein-associated phospholipase A2 with classical risk factors on coronary heart disease: a multi-ethnic study in China. Cellular physiology and biochemistry, 40, 953–968.
PubMed Web of Science ®Google Scholar
Geng, J.G., Chen, M., and Chou, K.C., 2004. P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Current medicinal chemistry, 11, 2153–2160.
PubMed Web of Science ®Google Scholar
Gerber, P.A., et al., 2013. Smoking is associated with impaired long-term glucose metabolism in patients with type 1 diabetes mellitus. Nutrition, metabolism and cardiovascular disease, 23, 102–108.
PubMed Web of Science ®Google Scholar
Gessner, C., et al., 2005. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respiratory medicine, 99, 1229–1240.
PubMed Web of Science ®Google Scholar
Gijsberts, C.M., et al., 2015. Biomarkers of coronary artery disease differ between Asians and Caucasians in the general population. Global heart, 10, 301–311 e11.
PubMed Web of Science ®Google Scholar
Gillissen, A., 2011. [COPD: smoker's cough? No, life-threatening!]. MMW fortschritte der medizin, 153, 32.
PubMedGoogle Scholar
Gnasso, A., et al., 1984. Acute influence of smoking on plasma lipoproteins. Klinische wochenschrift, 62Suppl2, 36–42.
Google Scholar
Godinho Netto, A.C., et al., 2016. Fraction of exhaled nitric oxide measurements in the diagnoses of asthma in elderly patients. Clinical interventions in aging, 11, 623–629.
PubMed Web of Science ®Google Scholar
Golbahar, J., Rezaian, G., and Bararpour, H., 2004. Distribution of plasma total homocysteine concentrations in the healthy Iranians. Clinical biochemistry, 37, 149–151.
PubMed Web of Science ®Google Scholar
Gold, D.R., et al., 1996. Effects of cigarette smoking on lung function in adolescent boys and girls. The new England journal of medicine, 335, 931–937.
PubMed Web of Science ®Google Scholar
Goniewicz, M.L., et al., 2009. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer epidemiology, biomarkers & prevention, 18, 3421–3425.
PubMed Web of Science ®Google Scholar
Gordon, S.M. and Davidson, W.S., 2012. Apolipoprotein A-I mimetics and high-density lipoprotein function. Current opinion in endocrinology, diabetes, and obesity, 19, 109–114.
PubMed Web of Science ®Google Scholar
Greenblatt, D.J., 1979. Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Journal of the American geriatrics society, 27, 20–22.
PubMed Web of Science ®Google Scholar
Gross, M.D., et al., 2012. Circulating soluble intercellular adhesion molecule 1 and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults Study. Clinical chemistry, 58, 411–420.
PubMed Web of Science ®Google Scholar
Gryglewski, R.J., Dembinska-Kiec, A., and Korbut, R., 1978. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation. Acta biologica et medica germanica, 37, 715–723.
PubMedGoogle Scholar
Guerra, S., et al., 2009. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax, 64, 894–900.
PubMed Web of Science ®Google Scholar
Gulliford, M.C. and Ukoumunne, O.C., 2001. Determinants of glycated haemoglobin in the general population: associations with diet, alcohol and cigarette smoking. European journal of clinical nutrition, 55, 615–623.
PubMed Web of Science ®Google Scholar
Gupta, V. and Singh, D., 2013. Critical assessment of the value of sputum neutrophils. COPD, 10, 107–114.
PubMedGoogle Scholar
Gutierrez, C.M., et al., 2014. [New spirometric reference equations for healthy Chilean adults]. Revista medica de Chile, 142, 143–152.
PubMed Web of Science ®Google Scholar
Guven, F.M., et al., 2013. The importance of myeloperoxidase enzyme activity in the pathogenesis of Crimean-Congo haemorrhagic fever. Journal of medical microbiology, 62, 441–445.
PubMed Web of Science ®Google Scholar
Guy, H.J., et al., 1994. Inhomogeneity of pulmonary ventilation during sustained microgravity as determined by single-breath washouts. Journal of applied physiology (1985), 76, 1719–1729.
PubMed Web of Science ®Google Scholar
Hadfield, K.A., et al., 2013. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl). Biochemical journal, 449, 531–542.
PubMed Web of Science ®Google Scholar
Haffner, S.M., et al., 1985. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity. Arteriosclerosis, 5, 169–177.
PubMedGoogle Scholar
Halvorsen, B., et al., 2007. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scandinavian journal of clinical and laboratory investigation, 67, 604–611.
PubMed Web of Science ®Google Scholar
Hamilton, G. and Rath, B., 2015. Smoking, inflammation and small cell lung cancer: recent developments. Wiener medizinische wochenschrift (1946), 165, 379–386.
PubMed Web of Science ®Google Scholar
Hare, J.M., et al., 2002. Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure. Journal of the American college of cardiology, 40, 1114–1119.
PubMed Web of Science ®Google Scholar
Harman, S.M., et al., 2003. Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free radical biology & medicine, 35, 1301–1309.
PubMed Web of Science ®Google Scholar
Hatsukami, D.K., et al., 2005. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest, 128, 2528–2537.
PubMed Web of Science ®Google Scholar
Hecht, S.S., 1998. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical research in toxicology, 11, 559–603.
PubMed Web of Science ®Google Scholar
Hecht, S.S., 2008. Progress and challenges in selected areas of tobacco carcinogenesis. Chemical research in toxicology, 21, 160–171.
PubMed Web of Science ®Google Scholar
Hecht, S.S., et al., 2015. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine & tobacco research, 17, 704–709.
PubMed Web of Science ®Google Scholar
Hecht, S.S., et al., 2013. Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort study. Cancer letters, 334, 34–38.
PubMed Web of Science ®Google Scholar
Hedblad, B., et al., 2006. COHb% as a marker of cardiovascular risk in never smokers: results from a population-based cohort study. Scandinavian journal of public health, 34, 609–615.
PubMed Web of Science ®Google Scholar
Hedblad, B., et al., 2005. Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure. Atherosclerosis, 179, 177–183.
PubMed Web of Science ®Google Scholar
Hegde, S., et al., 2016. Estimation and correlation of salivary thiocyanate levels in periodontally healthy subjects, smokers, nonsmokers, and gutka-chewers with chronic periodontitis. Indian journal of dental research, 27, 12–14.
PubMedGoogle Scholar
Hertsgaard, L.A., et al., 2008. Exposure to a tobacco-specific lung carcinogen in adolescent versus adult smokers. Cancer epidemiology, biomarkers & prevention, 17, 3337–3343.
PubMed Web of Science ®Google Scholar
Higashimoto, Y., et al., 2008. Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology, 13, 128–133.
PubMed Web of Science ®Google Scholar
Higuchi, T., et al., 2016. Current cigarette smoking is a reversible cause of elevated white blood cell count: cross-sectional and longitudinal studies. Preventive medicine reports, 4, 417–422.
PubMedGoogle Scholar
Hijazi, Z., et al., 2013. Biomarkers in atrial fibrillation: a clinical review. European heart journal, 34, 1475–1480.
PubMed Web of Science ®Google Scholar
Hilton, S., et al., 2016. E-cigarettes, a safer alternative for teenagers? A UK focus group study of teenagers' views. BMJ open, 6, e013271.
PubMed Web of Science ®Google Scholar
Ho, E., et al., 2013a. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox biology, 1, 483–491.
PubMed Web of Science ®Google Scholar
Ho, G., et al., 2013b. Biomarkers of tobacco smoke exposure and asthma severity in adults. American journal of preventive medicine, 45, 703–709.
PubMed Web of Science ®Google Scholar
Hoffmeyer, F., et al., 2009. Leukotriene B4, 8-iso-prostaglandin F2 alpha, and pH in exhaled breath condensate from asymptomatic smokers. Journal of physiology and pharmacology, 60(Suppl 5), 57–60.
PubMed Web of Science ®Google Scholar
Hogan, S.L., et al., 2007. Association of cigarette smoking with albuminuria in the United States: the third National Health and Nutrition Examination Survey. Renal failure, 29, 133–142.
PubMed Web of Science ®Google Scholar
Hogg, J.C., et al., 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. The new England journal of medicine, 350, 2645–2653.
PubMed Web of Science ®Google Scholar
Hogg, J.C., Macklem, P.T., and Thurlbeck, W.M., 1968. Site and nature of airway obstruction in chronic obstructive lung disease. The new England journal of medicine, 278, 1355–1360.
PubMed Web of Science ®Google Scholar
Hogg, J.C., Mcdonough, J.E., and Suzuki, M., 2013. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest, 143, 1436–1443.
PubMed Web of Science ®Google Scholar
Hogman, M., et al., 2002. Increased nitric oxide elimination from the airways after smoking cessation. Clinical science (London), 103, 15–19.
PubMed Web of Science ®Google Scholar
Hokanson, J.M., et al., 2006. Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. The diabetes educator, 32, 562–570.
PubMed Web of Science ®Google Scholar
Holdenrieder, S., 2016. Biomarkers along the continuum of care in lung cancer. Scandinavian journal of clinical and laboratory investigation. supplementum, 245, S40–S45.
PubMedGoogle Scholar
Holt, P.G., 1987. Immune and inflammatory function in cigarette smokers. Thorax, 42, 241–249.
PubMed Web of Science ®Google Scholar
Holz, O., et al., 2014. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD. BMC pulmonary medicine, 14, 30.
PubMed Web of Science ®Google Scholar
Holzer, M., et al., 2013. Aging affects high-density lipoprotein composition and function. Biochimica et biophysica acta, 1831, 1442–1448.
PubMed Web of Science ®Google Scholar
Hovingh, G.K., Bochem, A.E., and Kastelein, J.J., 2010. Apolipoprotein A-I mimetic peptides. Current opinion in lipidology, 21, 481–486.
PubMed Web of Science ®Google Scholar
Hovingh, G.K., Rader, D.J., and Hegele, R.A., 2015. HDL re-examined. Current opinion in lipidology, 26, 127–132.
PubMed Web of Science ®Google Scholar
Hoy, A., et al., 2002. Growing significance of myeloperoxidase in non-infectious diseases. Clinical chemistry and laboratory medicine, 40, 2–8.
PubMed Web of Science ®Google Scholar
Hozawa, A., et al., 2006. Does the impact of smoking on coronary heart disease differ by low-density lipoprotein cholesterol level?: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation journal, 70, 1105–1110.
PubMed Web of Science ®Google Scholar
Hu, G., et al., 2010. Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest, 138, 20–31.
PubMed Web of Science ®Google Scholar
Hu, R., et al., 2005. Smoking, homocysteine and degree of arteriolar retinopathy. Atherosclerosis, 183, 95–100.
PubMed Web of Science ®Google Scholar
Hwang, S.J., et al., 1997. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation, 96, 4219–4225.
PubMed Web of Science ®Google Scholar
Ikeda, Y., et al., 1997. Effect of smoking on the prevalence of albuminuria in Japanese men with non-insulin-dependent diabetes mellitus. Diabetes research and clinical practice, 36, 57–61.
PubMed Web of Science ®Google Scholar
Ikitimur, B. and Karadag, B., 2010. Role of myeloperoxidase in cardiology. Future cardiology, 6, 693–702.
PubMedGoogle Scholar
Ikonomidis, I., et al., 2005. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. American heart journal, 149, 832–839.
PubMed Web of Science ®Google Scholar
Il'yasova, D., et al., 2012. Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI. Obesity (Silver Spring), 20, 2147–2150.
PubMed Web of Science ®Google Scholar
Imaizumi, S., et al., 2011. Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. Circulation journal, 75, 1533–1538.
PubMed Web of Science ®Google Scholar
Imaizumi, T., et al., 1990. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Heart and vessels, 5, 81–86.
PubMedGoogle Scholar
Imes, C.C. and Austin, M.A., 2013. Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics. Biological research for nursing, 15, 292–308.
PubMed Web of Science ®Google Scholar
Inonu, H., et al., 2012. Oxidative stress levels in exhaled breath condensate associated with COPD and smoking. Respiratory care, 57, 413–419.
PubMed Web of Science ®Google Scholar
Ishikawa, S., et al., 1997. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study. Thrombosis and haemostasis, 77, 890–893.
PubMed Web of Science ®Google Scholar
Issaq, H.J., Waybright, T.J., and Veenstra, T.D., 2011. Cancer biomarker discovery: opportunities and pitfalls in analytical methods. Electrophoresis, 32, 967–975.
PubMed Web of Science ®Google Scholar
Iwaoka, M., et al., 2014. Twelve weeks of smoking cessation therapy with varenicline increases the serum levels of apolipoprotein A-I only in the success group. Journal of cardiology, 64, 318–323.
PubMed Web of Science ®Google Scholar
Jain, R.B., 2016. Trends and variability in the levels of urinary thiocyanate, perchlorate, and nitrate by age, gender, race/ethnicity, smoking status, and exposure to environmental tobacco smoke over 2005-2012. Science of the total environment, 557–558, 221–230.
PubMed Web of Science ®Google Scholar
Janssen, L.J., 2001. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. American journal of physiology. Lung cellular and molecular physiology, 280, L1067–L1082.
PubMed Web of Science ®Google Scholar
Jha, P., et al., 2013. 21st-century hazards of smoking and benefits of cessation in the United States. The new England journal of medicine, 368, 341–350.
PubMed Web of Science ®Google Scholar
Ji, J., et al., 2014. Compartment differences of inflammatory activity in chronic obstructive pulmonary disease. Respiratory research, 15, 104.
PubMed Web of Science ®Google Scholar
Jiang, Y., Wang, X., and Hu, D., 2017. Mitochondrial alterations during oxidative stress in chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease, 12, 1153–1162.
PubMed Web of Science ®Google Scholar
Johns, D.P., Walters, J.A., and Walters, E.H., 2014. Diagnosis and early detection of COPD using spirometry. Journal of thoracic disease, 6, 1557–1569.
PubMed Web of Science ®Google Scholar
Joo, M.J., et al., 2013. Use of spirometry in the diagnosis of COPD: a qualitative study in primary care. COPD, 10, 444–449.
PubMedGoogle Scholar
Kamat, G.V., et al., 2010. A cross-sectional study to detect the prevalence of hyperhomocysteinemia in cases of deep vein thrombosis. The Indian journal of surgery, 72, 323–326.
PubMed Web of Science ®Google Scholar
Kannel, W.B., et al., 1987. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA, 258, 1183–1186.
PubMed Web of Science ®Google Scholar
Kanner, R.E., et al., 1999. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. The American journal of medicine, 106, 410–416.
PubMed Web of Science ®Google Scholar
Kappelmayer, J., et al., 2004. The emerging value of P-selectin as a disease marker. Clinical chemistry and laboratory medicine, 42, 475–486.
PubMed Web of Science ®Google Scholar
Kar, D., et al., 2016. Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis. Cardiovascular diabetology, 15, 158.
PubMed Web of Science ®Google Scholar
Kawada, T., 2015. Relationships between the smoking status and plasma fibrinogen, white blood cell count and serum C-reactive protein in Japanese workers. Diabetes & Metabolic Syndrome, 9, 180–182.
PubMed Web of Science ®Google Scholar
Kaysen, G.A. and Levin, N.W., 2002. Why measure serum albumin levels? Journal of renal nutrition, 12, 148–150.
PubMed Web of Science ®Google Scholar
Keatings, V.M., et al., 1996. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. American journal of respiratory and critical care medicine, 153, 530–534.
PubMed Web of Science ®Google Scholar
Khan, N.A., et al., 2016. The effect of folic acid supplementation on hyperhomocysteinemia and pulmonary function parameters in chronic obstructive pulmonary disease: a pilot study. Journal of clinical and diagnostic research, 10, OC17–OC21.
PubMed Web of Science ®Google Scholar
Kharitonov, S.A. and Barnes, P.J., 2002. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals, 7, 1–32.
PubMed Web of Science ®Google Scholar
Kharitonov, S.A. and Barnes, P.J., 2006. Exhaled biomarkers. Chest, 130, 1541–1546.
PubMed Web of Science ®Google Scholar
Kharitonov, S.A., et al., 1995. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. American journal of respiratory and critical care medicine, 152, 609–612.
PubMed Web of Science ®Google Scholar
Khera, A., et al., 2005. Race and gender differences in C-reactive protein levels. Journal of the American college of cardiology, 46, 464–469.
PubMed Web of Science ®Google Scholar
Kim, H.O., et al., 2011. Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays. Journal of translational medicine, 9, 113.
PubMed Web of Science ®Google Scholar
King, C.C., et al., 2017. Longitudinal impact of smoking and smoking cessation on inflammatory markers of cardiovascular disease risk. Arteriosclerosis, thrombosis, and vascular biology, 37, 374–379.
PubMed Web of Science ®Google Scholar
Kleiner, G., et al., 2013. Cytokine levels in the serum of healthy subjects. Mediators of inflammation, 2013, 434010
PubMed Web of Science ®Google Scholar
Kleniewska, A., et al., 2016. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease. Journal of occupational health, 58, 333–339.
PubMed Web of Science ®Google Scholar
Koenig, W., 2003. Fibrin(ogen) in cardiovascular disease: an update. Thrombosis and haemostasis, 89, 601–609.
PubMed Web of Science ®Google Scholar
Koeth, R.A., Haselden, V., and Tang, W.H., 2013. Myeloperoxidase in cardiovascular disease. Advances in clinical chemistry, 62, 1–32.
PubMed Web of Science ®Google Scholar
Kontush, A. and Chapman, M.J., 2006. Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Nature clinical practice. Cardiovascular medicine, 3, 144–153.
PubMedGoogle Scholar
Korhonen, T., et al., 2011. Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women. Journal of womens health (Larchmt), 20, 1051–1064.
PubMed Web of Science ®Google Scholar
Kotani, K., et al., 2010. Influence of smoking habits on the GA/HbA1c ratio in patients with type 1 diabetes mellitus. Medical principles and practice: International journal of the Kuwait University, health science centre, 19, 415–417.
PubMed Web of Science ®Google Scholar
Kryfti, M., et al., 2015. Effects of smoking cessation on serum leptin and adiponectin levels. Tobacco induced diseases, 13, 30
PubMed Web of Science ®Google Scholar
Kubala, L., et al., 2008. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clinica chimica acta; International journal of clinical chemistry, 394, 59–62.
PubMed Web of Science ®Google Scholar
Kuban, P. and Foret, F., 2013. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review. Analytica chimica acta, 805, 1–18.
PubMed Web of Science ®Google Scholar
Kucharska-Newton, A.M., et al., 2008. HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study. Lung cancer (Amsterdam, Netherlands), 61, 292–300.
PubMed Web of Science ®Google Scholar
Kumari, M., Marmot, M., and Brunner, E., 2000. Social determinants of von willebrand factor: the Whitehall II study. Arteriosclerosis, thrombosis, and vascular biology, 20, 1842–1847.
PubMed Web of Science ®Google Scholar
Kverneland, A.H., et al., 2016. Age and gender leucocytes variances and references values generated using the standardized ONE-Study protocol. Cytometry part A, 89, 543–564.
PubMedGoogle Scholar
Lammertyn, L., et al., 2015. Ethnic-specific relationships between haemostatic and oxidative stress markers in black and white South Africans: the SABPA study. Clinical and experimental hypertension, 37, 511–517.
PubMed Web of Science ®Google Scholar
Lange, P., et al., 2003. Chronic bronchitis in an elderly population. Age and ageing, 32, 636–642.
PubMed Web of Science ®Google Scholar
Lappas, A.S., et al., 2016. Immediate effects of cigar smoking on respiratory mechanics and exhaled biomarkers; differences between young smokers with mild asthma and otherwise healthy young smokers. Tobacco induced diseases, 14, 29.
PubMed Web of Science ®Google Scholar
Lathe, R., Sapronova, A., and Kotelevtsev, Y., 2014. Atherosclerosis and Alzheimer–diseases with a common cause? Inflammation, oxysterols, vasculature. BMC geriatrics, 14, 36.
PubMed Web of Science ®Google Scholar
Lavange, L., et al., 2017. Spirometry reference equations from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos). American journal of respiratory and critical care medicine, 196, 993–1003.
PubMed Web of Science ®Google Scholar
Lee, D.S., et al., 2008. Clinical and genetic correlates of soluble P-selectin in the community. Journal of thrombosis and haemostasis, 6, 20–31.
PubMed Web of Science ®Google Scholar
Lee, J.S., et al., 2017. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study. Diabetes care, 40, 529–537.
PubMed Web of Science ®Google Scholar
Lee, P.N., et al., 2014. The effect of quitting smoking on white blood cell count: a review based on within-subject changes. Sutton, Surrey: P. N. Lees Statistics and Computing.
Google Scholar
Lee, P.N. and Forey, B.A., 2013. Indirectly estimated absolute lung cancer mortality rates by smoking status and histological type based on a systematic review. BMC cancer, 13, 189.
PubMed Web of Science ®Google Scholar
Lee, S.J., et al., 1993. Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Investigative ophthalmology & visual science, 34, 3522–3525.
PubMed Web of Science ®Google Scholar
Lee, W.J., et al., 2016. Soluble ICAM-1, independent of IL-6, is associated with prevalent frailty in community-dwelling elderly Taiwanese people. PLoS one, 11, e0157877.
PubMed Web of Science ®Google Scholar
Leman, L.J., Maryanoff, B.E., and Ghadiri, M.R., 2014. Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis. Journal of medicinal chemistry, 57, 2169–2196.
PubMed Web of Science ®Google Scholar
Lensmar, C., et al., 1998. Smoking alters the phenotype of macrophages in induced sputum. Respiratory medicine, 92, 415–420.
PubMed Web of Science ®Google Scholar
Lenting, P.J., et al., 2012. von Willebrand factor: the old, the new and the unknown. Journal of thrombosis and haemostasis, 10, 2428–2437.
PubMed Web of Science ®Google Scholar
Lenting, P.J., Denis, C.V., and Wohner, N., 2013. Von Willebrand factor and thrombosis: risk factor, actor and pharmacological target. Current vascular pharmacology, 11, 448–456.
PubMed Web of Science ®Google Scholar
Leone, A., 2015. Toxics of tobacco smoke and cardiovascular system: from functional to cellular damage. Current pharmaceutical design, 21, 4370–4379.
PubMed Web of Science ®Google Scholar
Leoni, V., et al., 2013. Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health. Journal of Alzheimer’s diseases, 36, 739–747.
PubMed Web of Science ®Google Scholar
Leung, J.M. and Sin, D.D., 2013. Biomarkers in airway diseases. Canadian respiratory journal, 20, 180–182.
PubMed Web of Science ®Google Scholar
Levitzky, Y.S., et al., 2008. Relation of smoking status to a panel of inflammatory markers: the Framingham offspring. Atherosclerosis, 201, 217–224.
PubMed Web of Science ®Google Scholar
Li, D., et al., 2017. Lipoprotein-associated phospholipase A2 in coronary heart disease: review and meta-analysis. Clinica chimica acta, 465, 22–29.
PubMed Web of Science ®Google Scholar
Life Sciences Research Office., 2007. Biological effects assessment in the evaluation of potential reduced-risk tobacco products. Bethesda: Life Sciences Research Office, Inc.
Google Scholar
Lim, E., Miyamura, J., and Chen, J.J., 2015. Racial/ethnic-specific reference intervals for common laboratory tests: a comparison among Asians, blacks, hispanics, and white. Hawaii journal of medicine & public health, 74, 302–310.
Google Scholar
Lim, E.M., et al., 2010. Race-specific WBC and neutrophil count reference intervals. International journal of laboratory hematology, 32, 590–597.
PubMed Web of Science ®Google Scholar
Lind, P., et al., 2004. Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins. Arteriosclerosis, thrombosis, and vascular biology, 24, 577–582.
PubMed Web of Science ®Google Scholar
Lip, G.Y. and Blann, A.D., 1995. von Willebrand factor and its relevance to cardiovascular disorders. British heart journal, 74, 580–583.
PubMedGoogle Scholar
Liu, J., et al., 2011. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer epidemiology, biomarkers & prevention, 20, 1760–1769.
PubMed Web of Science ®Google Scholar
Lobbes, M.B., et al., 2010. Leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach. International journal of vascular medicine, 2010, 726207.
PubMedGoogle Scholar
Lock-Johansson, S., Vestbo, J., and Sorensen, G.L., 2014. Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease. Respiratory research, 15, 147.
PubMed Web of Science ®Google Scholar
Lopez-Campos, J.L., et al., 2012. Increased levels of soluble ICAM-1 in chronic obstructive pulmonary disease and resistant smokers are related to active smoking. Biomarkers in medicine, 6, 805–811.
PubMed Web of Science ®Google Scholar
Loscalzo, J., 2001. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circulation research, 88, 756–762.
PubMed Web of Science ®Google Scholar
Lowe, F.J., Gregg, E.O., and Mcewan, M., 2009. Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. Clinical chemistry and laboratory medicine, 47, 311–320.
PubMed Web of Science ®Google Scholar
Lowe, G.D. and Pepys, M.B., 2006. C-reactive protein and cardiovascular disease: weighing the evidence. Current atherosclerosis reports, 8, 421–428.
PubMedGoogle Scholar
Lowe, G.D., et al., 2001. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?. Arteriosclerosis, thrombosis, and vascular biology, 21, 603–610.
PubMed Web of Science ®Google Scholar
Lp-PLA(2) Studies Collaboration, et al., 2010. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet, 375, 1536–1544.
PubMed Web of Science ®Google Scholar
Lu, J., et al., 2012. Profiling plasma peptides for the identification of potential ageing biomarkers in Chinese Han adults. PLoS one, 7, e39726.
PubMed Web of Science ®Google Scholar
Lüdicke, F., et al., 2016. Evaluation of biomarkers of exposure in smokers switching to a carbon-heated tobacco product: a controlled, randomized, open-label 5-day exposure study. Nicotine & tobacco research, 18, 1606–1613.
PubMed Web of Science ®Google Scholar
Lüdicke, F., et al., 2017. Effects of switching to the menthol tobacco heating system 2.2, Smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine & tobacco research. doi: 10.1093/ntr/ntx028. [Epub ahead of print]
PubMed Web of Science ®Google Scholar
Ludviksdottir, D., et al., 1999. Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. Journal of internal medicine, 246, 61–66.
PubMed Web of Science ®Google Scholar
Lupia, E., et al., 2010. Thrombopoietin contributes to enhanced platelet activation in cigarette smokers. Atherosclerosis, 210, 314–319.
PubMed Web of Science ®Google Scholar
Luthje, S., et al., 2013. Plasma membrane electron pathways and oxidative stress. Antioxidants & redox signaling, 18, 2163–2183.
PubMed Web of Science ®Google Scholar
Lutsey, P.L., et al., 2006. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. Journal of thrombosis and haemostasis, 4, 2629–2635.
PubMed Web of Science ®Google Scholar
Macnee, W., et al., 1989. The effect of cigarette smoking on neutrophil kinetics in human lungs. The new England journal of medicine, 321, 924–928.
PubMed Web of Science ®Google Scholar
Madjid, M., et al., 2004. Leukocyte count and coronary heart disease: implications for risk assessment. Journal of the American college of cardiology, 44, 1945–1956.
PubMed Web of Science ®Google Scholar
Maestrelli, P., et al., 1996. Integrin upregulation on sputum neutrophils in smokers with chronic airway obstruction. American journal of respiratory and critical care medicine, 154, 1296–1300.
PubMed Web of Science ®Google Scholar
Malik, I., et al., 2001. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet, 358, 971–976.
PubMed Web of Science ®Google Scholar
Malinovschi, A., et al., 2012. The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms. Respiratory medicine, 106, 794–801.
PubMed Web of Science ®Google Scholar
Mandraffino, G., et al., 2017. Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. Atherosclerosis, 257, 109–115.
PubMed Web of Science ®Google Scholar
Marano, K.M., et al., 2015. Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey. Inhalation toxicology, 27, 167–173.
PubMed Web of Science ®Google Scholar
Marti-Carvajal, A.J., et al., 2013. Homocysteine-lowering interventions for preventing cardiovascular events. The Cochrane database of systematic reviews, 1, CD006612.
PubMed Web of Science ®Google Scholar
Martin, F., et al., 2017. Quantifying the risk-reduction potential of new modified risk tobacco products. Regulatory toxicology and pharmacology. doi: 10.1016/j.yrtph.2017.12.011. [Epub ahead of print].
Web of Science ®Google Scholar
Martin Leroy, C., et al., 2012. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: a one-month, randomized, ambulatory, controlled clinical study in Poland. Regulatory toxicology and pharmacology, 64, S74–S84.
PubMed Web of Science ®Google Scholar
Martini, F., et al., 2005. Plasma von Willebrand factor antigen levels in non-small cell lung cancer patients. Anticancer research, 25, 403–407.
PubMed Web of Science ®Google Scholar
Masarei, J.R., et al., 1991. Effect of smoking cessation on serum apolipoprotein A-I and A-II concentrations. Pathology, 23, 98–102.
PubMed Web of Science ®Google Scholar
Maskey-Warzechowska, M., et al., 2017. Acute response to cigarette smoking assessed in exhaled breath condensate in patients with chronic obstructive pulmonary disease and healthy smokers. Advances in experimental medicine and biology, 944, 73–80.
PubMed Web of Science ®Google Scholar
Maurya, P.K., et al., 2016. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder. Progress in neuropsychopharmacology & biological psychiatry, 65, 134–144.
PubMed Web of Science ®Google Scholar
Mcadam, B.F., et al., 2005. Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. Circulation, 112, 1024–1029.
PubMed Web of Science ®Google Scholar
Mceligot, A.J., et al., 2006. Responsiveness of homocysteine concentrations to food and supplemental folate intakes in smokers and never-smokers enrolled in a diet intervention trial. Nicotine & tobacco research, 8, 57–66.
PubMed Web of Science ®Google Scholar
Mcgrath, C.R., Hitchcock, D.C., and Van Assendelft, O.W., 1982. Total white blood cell counts for persons ages 1-74 years with differential leukocyte counts for adults ages 25-74 years: United States, 1971-75. Vital and health statistics, 11, 1–36.
Google Scholar
Mcguinness, A.J. and Sapey, E., 2017. Oxidative stress in COPD: sources, markers, and potential mechanisms. Journal of clinical medicine, 6, E21.
PubMed Web of Science ®Google Scholar
Mclain, J.H., Alsterda, A.J., and Arora, R.R., 2016. Cholesteryl ester transfer protein inhibitors: trials and tribulations. Journal of cardiovascular pharmacology and therapy. pii: 1074248416662349. [Epub ahead of print]
PubMed Web of Science ®Google Scholar
Mehrotra, N., et al., 2010. Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score. Annals of epidemiology, 20, 223–232.
PubMed Web of Science ®Google Scholar
Merten, M. and Thiagarajan, P., 2004. P-selectin in arterial thrombosis. Zeitschrift fur kardiologie, 93, 855–863.
PubMedGoogle Scholar
Messner, B. and Bernhard, D., 2014. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arteriosclerosis, thrombosis, and vascular biology, 34, 509–515.
PubMed Web of Science ®Google Scholar
Metcalf, P.A., et al., 1993. Albuminuria in people at least 40 years old: effect of alcohol consumption, regular exercise, and cigarette smoking. Clinical chemistry, 39, 1793–1797.
PubMed Web of Science ®Google Scholar
Meuwese, M.C., et al., 2007. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. Journal of the American college of cardiology, 50, 159–165.
PubMed Web of Science ®Google Scholar
Miao Jonasson, J., et al., 2012. HbA1C and cancer risk in patients with type 2 diabetes: a nationwide population-based prospective cohort study in Sweden. PLoS one, 7, e38784.
PubMed Web of Science ®Google Scholar
Miles, E.A., et al., 2001. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clinical science, 100, 91–100.
PubMed Web of Science ®Google Scholar
Miller, M.A. and Cappuccio, F.P., 2007. Ethnicity and inflammatory pathways: implications for vascular disease, vascular risk and therapeutic intervention. Current medicinal chemistry, 14, 1409–1425.
PubMed Web of Science ®Google Scholar
Mirabelli, M.C., et al., 2016. Lung function decline over 25 years of follow-up among black and white adults in the ARIC study cohort. Respiratory medicine, 113, 57–64.
PubMed Web of Science ®Google Scholar
Mol, M.J., et al., 1997. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis, 129, 169–176.
PubMed Web of Science ®Google Scholar
Molassiotis, A., et al., 2010a. Interventions for cough in cancer. The Cochrane database of systematic reviews, 5, CD007881.
PubMedGoogle Scholar
Molassiotis, A., et al., 2010b. Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: a systematic review of the literature. Respiratory medicine, 104, 934–944.
PubMed Web of Science ®Google Scholar
Mons, U., et al., 2016. Effect of smoking reduction and cessation on the plasma levels of the oxidative stress biomarker glutathione – post-hoc analysis of data from a smoking cessation trial. Free radical biology & medicine, 91, 172–177.
PubMed Web of Science ®Google Scholar
Moore, P.K., 1982. Prostaglandins, prostacyclin and thromboxanes. Biochemical education, 10, 82–87.
Google Scholar
Moreira, M.A., et al., 2013. Pulmonary changes on HRCT scans in nonsmoking females with COPD due to wood smoke exposure. Jornal Brasileiro de pneumologia, 39, 155–163.
PubMed Web of Science ®Google Scholar
Morgan, P.E., et al., 2011. High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase. Free radical biology & medicine, 51, 1815–1822.
PubMed Web of Science ®Google Scholar
Morita, H., et al., 2005. Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. Journal of the American college of cardiology, 45, 589–594.
PubMed Web of Science ®Google Scholar
Morrow, J.D., 2005. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arteriosclerosis, thrombosis, and vascular biology, 25, 279–286.
PubMed Web of Science ®Google Scholar
Morrow, J.D., et al., 1995. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. New England journal of medicine, 332, 1198–1203., 2nd,
PubMed Web of Science ®Google Scholar
Morrow, J.D., et al., 1990. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proceedings of the national academy of sciences of the United States of America, 87, 9383–9387.
PubMed Web of Science ®Google Scholar
Muenchhoff, J., et al., 2017. Plasma apolipoproteins and physical and cognitive health in very old individuals. Neurobiology of Aging, 55, 49–60.
PubMed Web of Science ®Google Scholar
Nadif, R., et al., 2010. Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. Annals of allergy, asthma, & immunology, 104, 385–393.
PubMed Web of Science ®Google Scholar
Nakahata, N., 2008. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacology &Amp; therapeutics, 118, 18–35.
PubMed Web of Science ®Google Scholar
Nakos, G., et al., 2005. Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Critical care medicine, 33, 772–779.
PubMed Web of Science ®Google Scholar
Nakos, G., Tsangaris, I., and Lekka, M.E., 2004. Platelet-activating factor acetylhydrolase and acute respiratory distress syndrome: unanswered questions. Critical care medicine, 32, 1434–1435.
PubMed Web of Science ®Google Scholar
Nalls, M.A., et al., 2008. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. The American journal of human genetics, 82, 81–87.
PubMed Web of Science ®Google Scholar
Nash, M.C., et al., 1996. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clinical and experimental immunology, 103, 167–170.
PubMed Web of Science ®Google Scholar
Neubauer, H., et al., 2009. Upregulation of platelet CD40, CD40 ligand (CD40L) and P-Selectin expression in cigarette smokers: a flow cytometry study. Blood coagulation & fibrinolysis, 20, 694–698.
PubMed Web of Science ®Google Scholar
Niccoli, G., Dato, I., and Crea, F., 2010. Myeloperoxidase may help to differentiate coronary plaque erosion from plaque rupture in patients with acute coronary syndromes. Trends in cardiovascular medicine, 20, 276–281.
PubMed Web of Science ®Google Scholar
Nicholls, S.J. and Hazen, S.L., 2005. Myeloperoxidase and cardiovascular disease. Arteriosclerosis, thrombosis, and vascular biology, 25, 1102–1111.
PubMed Web of Science ®Google Scholar
Nilsson, G., et al., 2009. Ten-year survival in 75-year-old men and women: predictive ability of total cholesterol, HDL-C, and LDL-C. Current gerontology and geriatrics research, 2009, 158425.
PubMedGoogle Scholar
Nilsson, P.M., et al., 1995. Increased level of hemoglobin A1c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism, 44, 557–561.
PubMed Web of Science ®Google Scholar
Nordskog, B.K., et al., 2015. Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect. Inhalation toxicology, 27, 157–166.
PubMed Web of Science ®Google Scholar
Nowak, J., et al., 1987. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation, 76 (1), 6–14.
PubMed Web of Science ®Google Scholar
Nussbaum, C., et al., 2013. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxidants & redox signaling, 18, 692–713.
PubMed Web of Science ®Google Scholar
Nutt, D.J., et al., 2014. Estimating the harms of nicotine-containing products using the MCDA approach. European addiction research, 20, 218–225.
PubMed Web of Science ®Google Scholar
Nyberg, M., et al., 2014. Biomarkers of vascular function in premenopausal and recent postmenopausal women of similar age: effect of exercise training. American journal of physiology. Regulatory, integrative and comparative physiology, 306, R510–R517.
PubMed Web of Science ®Google Scholar
Nygard, O., et al., 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. The new England journal of medicine, 337, 230–236.
PubMed Web of Science ®Google Scholar
Nygard, O., et al., 1998. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. The American journal of clinical nutrition, 67, 263–270.
PubMed Web of Science ®Google Scholar
Nygard, O., et al., 1995. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA, 274, 1526–1533.
PubMed Web of Science ®Google Scholar
O'callaghan, P., et al., 2002. Smoking and plasma homocysteine. European heart journal, 23, 1580–1586.
PubMed Web of Science ®Google Scholar
O'callaghan, P.A., et al., 2005. New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers. European journal of cardiovascular prevention & rehabilitation, 12, 542–547.
PubMedGoogle Scholar
Obersby, D., et al., 2013. Plasma total homocysteine status of vegetarians compared with omnivores: a systematic review and meta-analysis. British journal of nutrition, 109, 785–794.
PubMed Web of Science ®Google Scholar
Ohkuma, T., et al., 2015. Dose- and time-dependent association of smoking and its cessation with glycemic control and insulin resistance in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. PLoS one, 10, e0122023.
PubMed Web of Science ®Google Scholar
Olkkonen, V.M., 2012. Macrophage oxysterols and their binding proteins: roles in atherosclerosis. Current opinion in lipidology, 23, 462–470.
PubMed Web of Science ®Google Scholar
Olsen, B.N., et al., 2012. Side-chain oxysterols: from cells to membranes to molecules. Biochimica et biophysica acta, 1818, 330–336.
PubMed Web of Science ®Google Scholar
Orth, S.R., 2002. Cigarette smoking: an important renal risk factor – far beyond carcinogenesis. Tobacco induced diseases, 1, 137–155.
PubMedGoogle Scholar
Osterud, B., et al., 1999. Haemostatic parameters related to lipids and adhesion molecules. Blood coagulation & fibrinolysis, 10, 465–470.
PubMed Web of Science ®Google Scholar
Otokozawa, S., et al., 2010. Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study. Atherosclerosis, 213, 251–255.
PubMed Web of Science ®Google Scholar
Paalani, M., et al., 2011. Determinants of inflammatory markers in a bi-ethnic population. Ethnicity &Amp; disease, 21, 142–149.
PubMed Web of Science ®Google Scholar
Pacilli, A., et al., 2013. Role of relationship between HbA1c, fibrinogen and HDL-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus. Atherosclerosis, 228, 247–248.
PubMed Web of Science ®Google Scholar
Pallasaho, P., et al., 2014. Combined effect of smoking and occupational exposure to dusts, gases or fumes on the incidence of COPD. COPD, 11, 88–95.
PubMedGoogle Scholar
Paone, G., et al., 2011. Analysis of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients. Disease markers, 31, 91–100.
PubMed Web of Science ®Google Scholar
Paramo, J.A., et al., 2004. Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease. Haematologica, 89, 1226–1231.
PubMed Web of Science ®Google Scholar
Park, H.Y., et al., 2013. The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD). PLoS one, 8, e61315.
PubMed Web of Science ®Google Scholar
Paulinska, P., Spiel, A., and Jilma, B., 2009. Role of von Willebrand factor in vascular disease. Hamostaseologie, 29, 32–38.
PubMed Web of Science ®Google Scholar
Payne, A.B., et al., 2014. High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites. Ethnicity & disease, 24, 169–174.
PubMed Web of Science ®Google Scholar
Pearson, T.A., et al., 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499–511.
PubMed Web of Science ®Google Scholar
Pena-Pereira, F., Lavilla, I., and Bendicho, C., 2016. Paper-based analytical device for instrumental-free detection of thiocyanate in saliva as a biomarker of tobacco smoke exposure. Talanta, 147, 390–396.
PubMed Web of Science ®Google Scholar
Pepys, M.B., 2005. CRP or not CRP? That is the question. Arteriosclerosis, thrombosis, and vascular biology, 25, 1091–1094.
PubMed Web of Science ®Google Scholar
Persson, M., et al., 2007. The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort. Atherosclerosis, 190, 388–396.
PubMed Web of Science ®Google Scholar
Petrescu, F., Voican, S.C., and Silosi, I., 2010. Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. International journal of chronic obstructive pulmonary disease, 5, 217–222.
PubMedGoogle Scholar
Pezzuto, A., et al., 2013. Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level. Journal of comparative effectiveness research, 2, 335–343.
PubMed Web of Science ®Google Scholar
Pignatti, P., et al., 2011. Age-related increase of airway neutrophils in older healthy nonsmoking subjects. Rejuvenation research, 14, 365–370.
PubMed Web of Science ®Google Scholar
Pinto-Sietsma, S.J., et al., 2000. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Annals of internal medicine, 133, 585–591.
PubMed Web of Science ®Google Scholar
Polley, L., et al., 2008. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest, 134, 295–302.
PubMed Web of Science ®Google Scholar
Poste, G., 2011. Bring on the biomarkers. Nature, 469, 156–157.
PubMed Web of Science ®Google Scholar
Pownall, H.J. and Gotto, A.M., Jr., 2016. New insights into the high-density lipoprotein dilemma. Trends in endocrinology and metabolism, 27, 44–53.
PubMed Web of Science ®Google Scholar
Prasad, G.L., et al., 2016. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers. Clinical chemistry and laboratory medicine, 54, 633–642.
PubMed Web of Science ®Google Scholar
Putcha, N., et al., 2014. Chronic productive cough is associated with death in smokers with early COPD. COPD, 11, 451–458.
PubMedGoogle Scholar
Quanjer, P.H., et al., 2012a. Age- and height-based prediction bias in spirometry reference equations. The European respiratory journal, 40, 190–197.
PubMed Web of Science ®Google Scholar
Quanjer, P.H., et al., 2012b. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. The European respiratory journal, 40, 1324–1343.
PubMed Web of Science ®Google Scholar
Quanjer, P.H., et al., 2014. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. The European respiratory journal, 43, 1051–1058.
PubMed Web of Science ®Google Scholar
Racherla, S. and Arora, R., 2012. Utility of Lp-PLA2 in lipid-lowering therapy. American journal of therapeutics, 19, 115–120.
PubMed Web of Science ®Google Scholar
Ramirez-Venegas, A., et al., 2014. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. American journal of respiratory and critical care medicine, 190, 996–1002.
PubMed Web of Science ®Google Scholar
Rangemark, C., et al., 1992. Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. Circulation, 86, 1495–1500.
PubMed Web of Science ®Google Scholar
Rangemark, C., Ciabattoni, G., and Wennmalm, A., 1993. Excretion of thromboxane metabolites in healthy women after cessation of smoking. Arteriosclerosis and thrombosis, 13, 777–782.
PubMed Web of Science ®Google Scholar
Rangemark, C. and Wennmalm, A., 1991. Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. Clinical science (London, England: 1979), 81, 11–15.
PubMed Web of Science ®Google Scholar
Rangemark, C. and Wennmalm, A., 1996. Smoke-derived nitric oxide and vascular prostacyclin are unable to counteract the platelet effect of increased thromboxane formation in healthy female smokers. Clinical physiology, 16, 301–315.
PubMedGoogle Scholar
Refsum, H., et al., 2006. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. Journal of nutrition, 136, 1731S–1740S.
PubMed Web of Science ®Google Scholar
Reilly, M., et al., 1996. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation, 94, 19–25.
PubMed Web of Science ®Google Scholar
Richter, E., et al., 2009. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man. Chemical research in toxicology, 22, 1008–1017.
PubMed Web of Science ®Google Scholar
Ridker, P.M., Buring, J.E., and Rifai, N., 2001. Soluble P-selectin and the risk of future cardiovascular events. Circulation, 103, 491–495.
PubMed Web of Science ®Google Scholar
Ridker, P.M., et al., 1998. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet, 351, 88–92.
PubMed Web of Science ®Google Scholar
Ridker, P.M., et al., 2000. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation, 101, 2149–2153.
PubMed Web of Science ®Google Scholar
Riise, G.C., et al., 1994. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. The European respiratory journal, 7, 1673–1677.
PubMed Web of Science ®Google Scholar
Robbins, R.A., et al., 1997. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest, 112, 313–318.
PubMed Web of Science ®Google Scholar
Roethig, H.J., et al., 2008. A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. The journal of clinical pharmacology, 48, 580–591.
PubMed Web of Science ®Google Scholar
Roethig, H.J., et al., 2010. Short term effects of reduced exposure to cigarette smoke on white blood cells, platelets and red blood cells in adult cigarette smokers. Regulatory toxicology and pharmacology, 57, 333–337.
PubMed Web of Science ®Google Scholar
Roethig, H.J., et al., 2007. Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. The journal of clinical pharmacology, 47, 518–530.
PubMed Web of Science ®Google Scholar
Rosenberg, S.R. and Kalhan, R., 2012. Biomarkers in chronic obstructive pulmonary disease. Translational research: the journal of laboratory and clinical medicine, 159, 228–237.
PubMed Web of Science ®Google Scholar
Rudolph, T.K., Rudolph, V., and Baldus, S., 2008. Contribution of myeloperoxidase to smoking-dependent vascular inflammation. Proceedings of the American thoracic society, 5, 820–823.
PubMedGoogle Scholar
Rudolph, T.K., et al., 2012. Myeloperoxidase deficiency preserves vasomotor function in humans. European heart journal, 33, 1625–1634.
PubMed Web of Science ®Google Scholar
Rufino, R., et al., 2017. Spirometry reference values in the Brazilian population. Brazilian journal of medical and biological research, 50, e5700
PubMed Web of Science ®Google Scholar
Ruggiero, C., et al., 2007. White blood cell count and mortality in the Baltimore longitudinal study of aging. Journal of the American college of cardiology, 49, 1841–1850.
PubMed Web of Science ®Google Scholar
Runarsdottir, S.B., et al., 2013. Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study. COPD, 10, 493–499.
PubMedGoogle Scholar
Rusznak, C., et al., 2000. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. American journal of respiratory cell and molecular biology, 23, 530–536.
PubMed Web of Science ®Google Scholar
Saareks, V., et al., 2001. Effects of smoking cessation and nicotine substitution on systemic eicosanoid production in man. Naunyn-Schmiedeberg’s archives of pharmacology, 363, 556–561.
PubMed Web of Science ®Google Scholar
Sadler, J.E., 1998. Biochemistry and genetics of von Willebrand factor. Annual review of biochemistry, 67, 395–424.
PubMed Web of Science ®Google Scholar
Salive, M.E., et al., 1992. Serum albumin in older persons: relationship with age and health status. Journal of clinical epidemiology, 45, 213–221.
PubMed Web of Science ®Google Scholar
Sapey, E., et al., 2008. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax, 63, 493–499.
PubMed Web of Science ®Google Scholar
Sato, K., et al., 2014. Association between plasma adiponectin levels and decline in forced expiratory volume in 1 s in a general Japanese population: the Takahata study. International journal of medical science, 11, 758–764.
PubMed Web of Science ®Google Scholar
Sayyah-Melli, M., et al., 2016. The effect of high dose folic acid throughout pregnancy on homocysteine (hcy) concentration and pre-eclampsia: a randomized clinical trial. PLoS one, 11, e0154400.
PubMed Web of Science ®Google Scholar
Sbarouni, E., Georgiadou, P., and Voudris, V., 2011. Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures. Biomarkers, 16, 457–465.
PubMed Web of Science ®Google Scholar
Scherer, G., 2006. Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Experimental and toxicologic pathology, 58, 101–124.
PubMed Web of Science ®Google Scholar
Schindhelm, R.K., et al., 2009. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?. Clinical chemistry, 55, 1462–1470.
PubMed Web of Science ®Google Scholar
Schwab, K.O., et al., 2008. Marked smoking-associated increase of cardiovascular risk in childhood type 1 diabetes. International journal of adolescent medicine and health, 20, 285–292.
PubMedGoogle Scholar
Schwartz, G.G., et al., 2012. Effects of dalcetrapib in patients with a recent acute coronary syndrome. New England journal of medicine, 367, 2089–2099.
PubMed Web of Science ®Google Scholar
Seemungal, T.A., et al., 2007. Plasma homocysteine is elevated in COPD patients and is related to COPD severity. International journal of chronic obstructive pulmonary disease, 2, 313–321.
PubMedGoogle Scholar
Shankar, S., Suchetha, K.N., and Madhu, L.N., 2012. Variations in serum myeloperoxidase levels with respect to hyperglycemia, duration of diabetes, BMI, sex and aging in type 2 diabetes mellitus. International journal of research in pharmaceutical and biomedical sciences, 3, 652–655.
Google Scholar
Shao, B., 2012. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. Biochimica et biophysica acta, 1821, 490–501.
PubMed Web of Science ®Google Scholar
Shao, B., et al., 2005. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. Journal of biological chemistry, 280, 36386–36396.
PubMed Web of Science ®Google Scholar
Sharifov, O.F., et al., 2013. Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. PLoS one, 8, e64486.
PubMed Web of Science ®Google Scholar
Sharma, G. and Berger, J.S., 2011. Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data. Journal of thrombosis and thrombolysis, 32, 201–208.
PubMed Web of Science ®Google Scholar
Sharma, G. and Goodwin, J., 2006. Effect of aging on respiratory system physiology and immunology. Clinical interventions in aging, 1, 253–260.
PubMed Web of Science ®Google Scholar
Sharma, S. and Lipincott, W., 2017. Biomarkers in Alzheimer's disease-recent update. Current Alzheimer research, doi: 10.2174/1567205014666170220141822. [Epub ahead of print]
PubMedGoogle Scholar
Sherman, C.B., et al., 1992. Longitudinal lung function decline in subjects with respiratory symptoms. The American review of respiratory disease, 146, 855–859.
PubMed Web of Science ®Google Scholar
Shibata, Y., et al., 2013. Relationship between plasma fibrinogen levels and pulmonary function in the Japanese population: the Takahata study. International journal of medical science, 10, 1530–1536.
PubMed Web of Science ®Google Scholar
Shiels, M.S., et al., 2014. Cigarette smoking and variations in systemic immune and inflammation markers. Journal of the national cancer institute, 106, dju294.
PubMedGoogle Scholar
Shinkai, H., 2012. Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases. Vascular health and risk management, 8, 323–331.
PubMedGoogle Scholar
Shiue, I., 2015. Urinary thiocyanate concentrations are associated with adult cancer and lung problems: US NHANES, 2009-2012. Environmental science and pollution research international, 22, 5952–5960.
PubMed Web of Science ®Google Scholar
Siemons, L., et al., 2014. How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis. BMC musculoskeletal disorders, 15, 368.
PubMed Web of Science ®Google Scholar
Sies, H., 2014. Role of metabolic H2O2 generation: redox signaling and oxidative stress. The journal of biological chemistry, 289, 8735–8741.
PubMed Web of Science ®Google Scholar
Simon, D., et al., 1989. Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The telecom study. Diabetologia, 32, 864–869.
PubMed Web of Science ®Google Scholar
Simpson, J.L., et al., 2013. Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD. Mediators of inflammation, 2013, 462934.
PubMed Web of Science ®Google Scholar
Singh, D., et al., 2010. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respiratory research, 11, 77
PubMed Web of Science ®Google Scholar
Sirnio, P., et al., 2017. Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer. Scientific reports, 7, 5374.
PubMed Web of Science ®Google Scholar
Skloot, G.S., 2017. The effects of aging on lung structure and function. Clinics in geriatric medicine, 33, 447–457.
PubMed Web of Science ®Google Scholar
Skoog, T., et al., 2002. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. European heart journal, 23, 376–383.
PubMed Web of Science ®Google Scholar
Skulachev, V.P., 2012. Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases. Journal of Alzheimer’s disease, 28, 283–289.
PubMed Web of Science ®Google Scholar
Smith, J.D., 2010. Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis. Current opinion in investigational drugs (London, England: 2000), 11, 989–996.
PubMedGoogle Scholar
Sobczak, A., et al., 2007. [The influence of tobacco smoke on homocysteine level in plasma of healthy males]. Przeglad lekarsi, 64, 679–684.
PubMedGoogle Scholar
Sobczak, A.J., 2003. The effects of tobacco smoke on the homocysteine level – a risk factor of atherosclerosis. Addiction biology, 8, 147–158.
PubMed Web of Science ®Google Scholar
Sonneveld, M.A., et al., 2015. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study. Thrombosis and haemostasis, 113, 577–584.
PubMed Web of Science ®Google Scholar
Spanevello, A., et al., 2000. Induced sputum cellularity. Reference values and distribution in normal volunteers. American journal of respiratory and critical care medicine, 162, 1172–1174.
PubMed Web of Science ®Google Scholar
Sparrow, D., et al., 1984. The relationship of the peripheral leukocyte count and cigarette smoking to pulmonary function among adult men. Chest, 86, 383–386.
PubMed Web of Science ®Google Scholar
Spiel, A.O., Gilbert, J.C., and Jilma, B., 2008. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation, 117, 1449–1459.
PubMed Web of Science ®Google Scholar
Stafforini, D.M., 2009. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovascular drugs and therapy, 23, 73–83.
PubMed Web of Science ®Google Scholar
Stepanov, I., et al., 2009. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine & tobacco research, 11, 99–105.
PubMed Web of Science ®Google Scholar
Stephen, R., et al., 2014. Albuminuria: when urine predicts kidney and cardiovascular disease. Cleveland clinic journal of medicine, 81, 41–50.
PubMed Web of Science ®Google Scholar
Stiles, A.R., et al., 2014. Genetic, anatomic, and clinical determinants of human serum sterol and vitamin D levels. Proceedings of the national academy of sciences of the United States of America, 111, E4006–E4014.
PubMed Web of Science ®Google Scholar
Stone, H., et al., 2012. Variability of sputum inflammatory mediators in COPD and alpha1-antitrypsin deficiency. European respiratory journal, 40, 561–569.
PubMed Web of Science ®Google Scholar
Strassburg, A., et al., 2004. Effect of age on plasma homocysteine concentrations in young and elderly subjects considering serum vitamin concentrations and different lifestyle factors. International journal of vitamin and nutrition research, 74, 129–136.
PubMed Web of Science ®Google Scholar
Stratton, K., et al., 2001. Clearing the smoke: the science base for tobacco harm reduction-executive summary. Tobacco control, 10, 189–195.
PubMed Web of Science ®Google Scholar
Strimbu, K. and Tavel, J.A., 2010. What are biomarkers?. Current opinion in HIV and AIDS, 5, 463–466.
PubMed Web of Science ®Google Scholar
Stubbe, I., Eskilsson, J., and Nilsson-Ehle, P., 1982. High-density lipoprotein concentrations increase after stopping smoking. British medical journal (Clinical Research Ed.), 284, 1511–1513.
PubMed Web of Science ®Google Scholar
Subar, A.F., Harlan, L.C., and Mattson, M.E., 1990. Food and nutrient intake differences between smokers and non-smokers in the US. American journal of public health, 80, 1323–1329.
PubMed Web of Science ®Google Scholar
Sugiura, H., et al., 2012. Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease. Respirology, 17, 533–540.
PubMed Web of Science ®Google Scholar
Sumino, H., et al., 1998. Decreased basal production of nitric oxide in patients with heart disease. Chest, 113, 317–322.
PubMed Web of Science ®Google Scholar
Sun, K., et al., 2017. Associations between homocysteine metabolism related SNPs and carotid intima-media thickness: a Chinese sib pair study. Journal of thrombosis and thrombolysis, 43, 401–410.
PubMed Web of Science ®Google Scholar
Sun, W., et al., 2016. Common genetic polymorphisms influence blood biomarker measurements in COPD. PLoS Genetics, 12, e1006011.
PubMed Web of Science ®Google Scholar
Sundy, J.S., et al., 2007. Smoking is associated with an age-related decline in exhaled nitric oxide. The European respiratory journal, 30, 1074–1081.
PubMed Web of Science ®Google Scholar
Swan, G.E., et al., 1991. Quantitative analysis of sputum cytologic differences between smokers and nonsmokers. Diagnostic cytopathology, 7, 569–575.
PubMed Web of Science ®Google Scholar
Szadkowski, A. and Myers, C.R., 2008. Acrolein oxidizes the cytosolic and mitochondrial thioredoxins in human endothelial cells. Toxicology, 243, 164–176.
PubMed Web of Science ®Google Scholar
Takizawa, H., et al., 2000. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. American journal of physiology-lung cellular and molecular physiology, 278, L906–L913.
PubMed Web of Science ®Google Scholar
Tall, A.R., 1998. An overview of reverse cholesterol transport. European heart journal, 19(SupplA), A31–A35.
Web of Science ®Google Scholar
Tan, D.B.A., et al., 2017. Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation. Respiratory medicine, 132, 261–264.
PubMed Web of Science ®Google Scholar
Tanni, S.E., et al., 2010. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. Journal of inflammation, 7, 29.
Google Scholar
Teixeira, P.C., Cutler, P., and Vuilleumier, N., 2012. Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives. Clinical and developmental immunology, 2012, 868251.
PubMedGoogle Scholar
Tell, G.S., et al., 1985. The relationship of white cell count, platelet count, and hematocrit to cigarette smoking in adolescents: the Oslo Youth Study. Circulation, 72, 971–974.
PubMed Web of Science ®Google Scholar
Tembe, N., et al., 2014. Reference values for clinical laboratory parameters in young adults in Maputo, Mozambique. PLoS one, 9, e97391.
PubMed Web of Science ®Google Scholar
Thanan, R., et al., 2014. Oxidative stress and its significant roles in neurodegenerative diseases and cancer. International journal of molecular sciences, 16, 193–217.
PubMed Web of Science ®Google Scholar
Thelle, D.S., Forde, O.H., and Arnesen, E., 1982. Distribution of high-density lipoprotein cholesterol according to age, sex, and ethnic origin: cardiovascular disease study in Finnmark 1977. Journal of epidemiology and community health, 36, 243–247.
PubMed Web of Science ®Google Scholar
Thomas, R.A., et al., 2004. The influence of age on induced sputum differential cell counts in normal subjects. Chest, 126, 1811–1814.
PubMed Web of Science ®Google Scholar
Thukkani, A.K., et al., 2003. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation, 108, 3128–3133.
PubMed Web of Science ®Google Scholar
Toljamo, T., et al., 2010. Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study. Scandinavian journal of primary health care, 28, 41–46.
PubMed Web of Science ®Google Scholar
Tommola, M., et al., 2016. The effect of smoking on lung function: a clinical study of adult-onset asthma. The European respiratory journal, 48, 1298–1306.
PubMed Web of Science ®Google Scholar
Tonstad, S. and Cowan, J.L., 2009. C-reactive protein as a predictor of disease in smokers and former smokers: a review. International journal of clinical practice, 63, 1634–1641.
PubMed Web of Science ®Google Scholar
Toren, K., et al., 2017. Reference values of fractional excretion of exhaled nitric oxide among non-smokers and current smokers. BMC pulmonary medicine, 17, 118.
PubMed Web of Science ®Google Scholar
Tran, B. and Kalhan, R., 2008. The emerging role of systemic inflammation in chronic obstructive pulmonary disease. Clinical pulmonary medicine, 15, 22–125.
Google Scholar
Tricker, A.R., 1997. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. European journal of cancer prevention, 6, 226–268.
PubMed Web of Science ®Google Scholar
Tricker, A.R., et al., 2012. Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 4: eight-day randomized clinical trial in Korea. Regulatory toxicology and pharmacology, 64, S45–S53.
PubMed Web of Science ®Google Scholar
Tsai, J.S., et al., 2012. Changes of serum adiponectin and soluble intercellular adhesion molecule-1 concentrations after smoking cessation. Clinical chemistry and laboratory medicine, 50, 1063–1069.
PubMed Web of Science ®Google Scholar
Tsao, M.S., et al., 2015. Predictive versus prognostic value of lung adenocarcinoma classification. Journal of clinical oncology, 33, 225–226.
PubMed Web of Science ®Google Scholar
Tselepis, A.D., et al., 2009. Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study. Atherosclerosis, 206, 303–308.
PubMed Web of Science ®Google Scholar
Tsimihodimos, V., et al., 2002. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB. Arteriosclerosis, thrombosis, and vascular biology, 22, 306–311.
PubMed Web of Science ®Google Scholar
Tsoumakidou, M., Tzanakis, N., and Siafakas, N.M., 2003. Induced sputum in the investigation of airway inflammation of COPD. Respiratory medicine, 97, 863–871.
PubMed Web of Science ®Google Scholar
Tsuda, M. and Kurashima, Y., 1991. Tobacco smoking, chewing, and snuff dipping: factors contributing to the endogenous formation of N-nitroso compounds. Critical reviews in toxicology, 21, 243–253.
PubMed Web of Science ®Google Scholar
Uedelhoven, W.M., et al., 1991. Smoking alters thromboxane metabolism in man. Biochimica et biophysica acta, 1081 (2), 197–201.
PubMedGoogle Scholar
Urrutia, I., et al., 2005. Smoking habit, respiratory symptoms and lung function in young adults. European journal of public health, 15, 160–165.
PubMed Web of Science ®Google Scholar
US Department of Health and Human Services. 2014. The health consequences of smoking-50 years of progress: a report of the surgeon general. Atlanta (GA): US Department of Health and Human Services.
Google Scholar
van't Erve, T.J., et al., 2016. Reinterpreting the best biomarker of oxidative stress: the 8-iso-prostaglandin F2alpha/prostaglandin F2alpha ratio shows complex origins of lipid peroxidation biomarkers in animal models. Free radical biology & medicine, 95, 65–73.
PubMed Web of Science ®Google Scholar
van't Erve, T.J., et al., 2017. Classifying oxidative stress by F2-isoprostane levels across human diseases: a meta-analysis. Redox biology, 12, 582–599.
PubMed Web of Science ®Google Scholar
van't Erve, T.J., et al., 2015. Reinterpreting the best biomarker of oxidative stress: the 8-iso-PGF(2alpha)/PGF(2alpha) ratio distinguishes chemical from enzymatic lipid peroxidation. Free radical biology & medicine, 83, 245–251.
PubMed Web of Science ®Google Scholar
Van Dijk, W., et al., 2015. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Annals of family medicine, 13, 41–48.
PubMed Web of Science ®Google Scholar
Van Galen, K.P., et al., 2012. Von Willebrand factor deficiency and atherosclerosis. Blood reviews, 26, 189–196.
PubMed Web of Science ®Google Scholar
Van Staden, S.R., et al., 2013. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. South African medical journal, 103, 865–868.
Google Scholar
Vardavas, C.I., et al., 2008. Smoking status in relation to serum folate and dietary vitamin intake. Tobacco induced diseases, 4, 8
PubMedGoogle Scholar
Vartanian, L.S. and Gurevich, S.M., 1989. [NADH- and NADPH-dependent formation of superoxide radicals in liver nuclei]. Biokhimiia, 54, 1020–1025.
PubMedGoogle Scholar
Veering, B.T., et al., 1990. The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein. British journal of clinical pharmacology, 29, 201–206.
PubMed Web of Science ®Google Scholar
Verbanck, S., et al., 2004. Noninvasive assessment of airway alterations in smokers: the small airways revisited. American journal of respiratory and critical care medicine, 170, 414–419.
PubMed Web of Science ®Google Scholar
Verleden, G.M., et al., 1999. The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naive asthmatics. Chest, 116, 59–64.
PubMed Web of Science ®Google Scholar
Vestbo, J., 2014. Chronic bronchitis: so much more than just a smoker's cough. The international journal of tuberculosis and lung disease, 18, 760.
PubMed Web of Science ®Google Scholar
Vestbo, J., et al., 2016. Global Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Gold Executive Summary. American journal of respiratory and critical care medicine, 187, 347–365.
Google Scholar
Viegi, G., et al., 1988a. Variability of maximal expiratory flow-volume curve in young volley players. Respiration, 54, 33–41.
PubMed Web of Science ®Google Scholar
Viegi, G., et al., 1988b. Prevalence of respiratory symptoms in an unpolluted area of northern Italy. The European respiratory journal, 1, 311–318.
PubMed Web of Science ®Google Scholar
Vischer, U.M., 2006. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. Journal of thrombosis and haemostasis, 4, 1186–1193.
PubMed Web of Science ®Google Scholar
Vittos, O., et al., 2012. Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker. Biomarkers, 17, 289–302.
PubMed Web of Science ®Google Scholar
Vlassopoulos, A., Lean, M.E., and Combet, E., 2013. Influence of smoking and diet on glycated haemoglobin and 'pre-diabetes' categorisation: a cross-sectional analysis. BMC public health, 13, 1013.
PubMed Web of Science ®Google Scholar
Voight, B.F., et al., 2012. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet, 380, 572–580.
PubMed Web of Science ®Google Scholar
Vollmer, W.M., et al., 1989. Respiratory symptoms, lung function, and mortality in a screening center cohort. American journal of epidemiology, 129, 1157–1169.
PubMed Web of Science ®Google Scholar
Voulgari, C., Katsilambros, N., and Tentolouris, N., 2011. Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study. Metabolism, 60, 1456–1464.
PubMed Web of Science ®Google Scholar
Vuilleumier, N., Montecucco, F., and Hartley, O., 2014. Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity. World journal of cardiology, 6, 314–326.
PubMedGoogle Scholar
Vuilleumier, N., et al., 2004. Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease. Journal of autoimmunity, 23, 353–360.
PubMed Web of Science ®Google Scholar
Wadhwani, N.S., et al., 2016. Increased homocysteine levels exist in women with preeclampsia from early pregnancy. The journal of maternal-fetal & neonatal medicine, 29, 2719–2725.
PubMed Web of Science ®Google Scholar
Wang, H., et al., 2001. Serum thiocyanate concentration as an indicator of smoking in relation to deaths from cancer. Environmental health and preventive medicine, 6, 88–91.
PubMedGoogle Scholar
Wang, Q., et al., 2015. Serum apolipoprotein A-1 quantification by LC-MS with a SILAC internal standard reveals reduced levels in smokers. Bioanalysis, 7, 2895–2911.
PubMed Web of Science ®Google Scholar
Wang, Z., et al., 2017. Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population. PeerJ, 5, e3156.
PubMed Web of Science ®Google Scholar
Wang, Z., et al., 2007. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nature medicine, 13, 1176–1184.
PubMed Web of Science ®Google Scholar
Wannamethee, S.G., et al., 2005. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European heart journal, 26, 1765–1773.
PubMed Web of Science ®Google Scholar
Weber, A.A., et al., 2000. Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects. Platelets, 11, 177–182.
PubMed Web of Science ®Google Scholar
Wei, B., et al., 2016. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012. Journal of exposure science and environmental epidemiology, 26, 249–256.
PubMed Web of Science ®Google Scholar
Wei, Y.F., et al., 2014. The impact of metabolic parameters on the change of pulmonary function in obese patients. Surgery of obesity and related diseases, 10, 23–28.
PubMed Web of Science ®Google Scholar
Wennmalm, A., et al., 1991. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation, 83, 1698–1704.
PubMed Web of Science ®Google Scholar
Wennmalm, A., et al., 1993. Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. Clinical physiology, 13, 257–264.
PubMedGoogle Scholar
Whereat, A.F., 1970. Is atherosclerosis a disorder of intramitochondrial respiration? Annals of internal medicine, 73, 125–127.
PubMed Web of Science ®Google Scholar
Whincup, P.H., et al., 2002. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. European heart journal, 23, 1764–1770.
PubMed Web of Science ®Google Scholar
Willemse, B.W., et al., 2005. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. The European respiratory journal, 26, 835–845.
PubMed Web of Science ®Google Scholar
Witkowska, A.M., 2005. Soluble ICAM-1: a marker of vascular inflammation and lifestyle. Cytokine, 31, 127–134.
PubMed Web of Science ®Google Scholar
Woloshin, S. and Schwartz, L.M., 2005. Distribution of C-reactive protein values in the United States. The new England journal of medicine, 352, 1611–1613.
PubMed Web of Science ®Google Scholar
Woodruff, P.G., et al., 2016. Clinical significance of symptoms in smokers with preserved pulmonary function. The new England journal of medicine, 374, 1811–1821.
PubMed Web of Science ®Google Scholar
Wu, L., et al., 2017. Effect of age on the diagnostic efficiency of HbA1c for diabetes in a Chinese middle-aged and elderly population: the Shanghai Changfeng Study. PLoS one, 12, e0184607.
PubMed Web of Science ®Google Scholar
Wu, W., et al., 2005. Determination of carcinogenic tobacco-specific nitrosamines in mainstream smoke from U.S.-brand and non-U.S.-brand cigarettes from 14 countries. Nicotine & tobacco research, 7, 443–451.
PubMed Web of Science ®Google Scholar
Wu, Y., et al., 2015. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients. International journal of chronic obstructive pulmonary disease, 10, 2405–2412.
PubMed Web of Science ®Google Scholar
Wyczalkowska-Tomasik, A., et al., 2016. Inflammatory markers change with age, but do not fall beyond reported normal ranges. Archivum immunologiae et therapiae experimentalis, 64, 249–254.
PubMed Web of Science ®Google Scholar
Xia, Y., et al., 2011. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008. Biomarkers, 16, 112–119.
PubMed Web of Science ®Google Scholar
Xie, Y., et al., 2017. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: a meta-analysis. Neuroscience letters, 636, 190–195.
PubMed Web of Science ®Google Scholar
Xu, X., et al., 2016. A population-based study of smoking, serum cotinine and exhaled nitric oxide among asthmatics and a healthy population in the USA. Inhalation toxicology, 28, 724–730.
PubMed Web of Science ®Google Scholar
Yanbaeva, D.G., et al., 2007. Systemic effects of smoking. Chest, 131, 1557–1566.
PubMed Web of Science ®Google Scholar
Yang, L., et al., 2017. Association between Lp-PLA2 and coronary heart disease in Chinese patients. The journal of international medical research, 45, 159–169.
PubMed Web of Science ®Google Scholar
Yates, D.H., Breen, H., and Thomas, P.S., 2001. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects. American journal of respiratory and critical care medicine, 164, 1043–1046.
PubMed Web of Science ®Google Scholar
Yeung, M.C. and Buncio, A.D., 1984. Leukocyte count, smoking, and lung function. The american journal of medicine, 76, 31–37.
PubMed Web of Science ®Google Scholar
Yoon, H.I. and Sin, D.D., 2011. Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature. Drugs, 71, 1821–1837.
PubMed Web of Science ®Google Scholar
Yuan, J., et al., 2015. Differences of plasma IL-1 and TNF-α in healthy Chinese population. Open medicine (Warsaw, Poland), 10, 306–310.
PubMedGoogle Scholar
Yuan, J.M., et al., 2011. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis, 32, 1366–1371.
PubMed Web of Science ®Google Scholar
Yuan, J.M., et al., 2009. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer research, 69, 2990–2995.
PubMed Web of Science ®Google Scholar
Zaynagetdinov, R., et al., 2016. Chronic NF-kappaB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs. Oncotarget, 7, 5470–5482.
PubMed Web of Science ®Google Scholar
Zelova, H. and Hosek, J., 2013. TNF-alpha signalling and inflammation: interactions between old acquaintances. Inflammation research, 62, 641–651.
PubMed Web of Science ®Google Scholar
Zezulka, A.V., Gill, J.S., and Beevers, D.G., 1987. 'Neutropenia' in black west Indians. Postgraduate medical journal, 63, 257–261.
PubMed Web of Science ®Google Scholar
Zhang, F., et al., 2016. The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer. Oncotarget, 8 (5), 8835–8842.
Web of Science ®Google Scholar
Zheng, L., et al., 2004. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. Journal of clinical investigation, 114, 529–541.
PubMed Web of Science ®Google Scholar
Zhou, Z., et al., 2014. Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts. PLoS one, 9, e84810.
PubMed Web of Science ®Google Scholar
Zhu, L., et al., 2016. A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Oncotargets and therapy, 9, 4879–4886.
PubMed Web of Science ®Google Scholar
Zil, A.R. and Rahman, M.A., 2006. Serum thiocyanate levels in smokers, passive smokers and never smokers. Journal of Pakistan medical association, 56, 323–326.
PubMedGoogle Scholar
Zuiker, R.G., et al., 2010. Sputum induction with hypertonic saline reduces fractional exhaled nitric oxide in chronic smokers and non-smokers. Respiratory medicine, 104, 917–920.
PubMed Web of Science ®Google Scholar
Zuiker, R.G., et al., 2015. Reproducibility of biomarkers in induced sputum and in serum from chronic smokers. Pulmonary pharmacology & therapeutics, 33, 81–86.
PubMed Web of Science ®Google Scholar

Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date